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ABSTRACT

Herrera-Perez, Ruth M. PhD, Purdue University, May 2016. Influence of the 3D
Microenvironment on Glioblastoma Migration and Drug Response. Major Professor:
Jenna L. Rickus, Department of Agricultural and Biological Engineering.

Glioblastoma (GBM) is a highly invasive brain cancer characterized by poor prognosis.
Despite significant efforts by the basic and clinical research community our
understanding of GBM progression and recurrence has been incremental. Improvements
in therapeutic response have been dismal, and GBM continues to be the deadliest tumor
of the central nervous system, with patient average survival rate of 12 months.
Synergistic relationships that the tumor cells establish with the brain microenvironment
have been proven fundamental for successful tumor progression and maintenance. Yet,
many in vitro GBM studies are performed in formats that fail to recapitulate the most
essential component of the tumor microenvironment.

In this work we aim to describe the influence of multiple features of the tumor
microenvironment on GBM migration characteristics and response to drug treatment. Our
approach involved the development of a 3D in vitro tissue model that recapitulates the
cellular, chemical and mechanical features of brain microenvironment. To assess the
influence of the physical properties of the extracellular matrix (ECM) on GBM migration

xvi
we developed a matrix of hyaluronan supported by collagen with embedded microfibers
to simulate the composition of brain ECM and the topographical cues of vasculature.
Comparison of this model with Matrigel and collagen type-I showed that GBM exhibits
different migration modes such as collective expansion, multicellular strands, and single
cell migration as a response to the ECM composition and stiffness. Further incorporation
of brain stromal cells as astrocytes and endothelial cells into the model showed that
presence of astrocytes increased the migration of all GBM cell lines studied, however
presence of endothelial cells only increased the migration of glioblastoma stem-like cells.
Evaluation of the cytotoxic effect of multiple drugs on GBM was performed using our 3D
model. Presence of extracellular matrix and stromal cells reduced the sensitivity of stemlike GBM cells to drug treatments. Our specific focus was on anti-STAT3 therapy and
data obtained in the 3D model showed that the microenvironment regulates STAT3
activation as well as response to STAT3 drug targeting.

This work supports the fundamental role of the 3D-microenvironment as a modulator of
GBM behavior and provides a consistent and tunable in vitro platform to be used in GBM
studies for a more realistic understanding of in vivo cancer progression and response to
therapy.

1

CHAPTER 1. INTRODUCTION

1.1

Objective

This thesis aims to contribute to the understanding of the tumor microenvironment as a
modulator of glioblastoma migration and drug response. To this end, we sought to bridge
conventional cancer cell culture and animal models by developing a tunable 3D platform
that recapitulates in vitro the physical, compositional and cellular components of
glioblastoma microenvironment. This model offers a more realistic platform to study in
controlled

fashion

the

influence

of

some

components

of

the

glioblastoma

microenvironment on tumor migration and survival after chemotherapeutic treatment.
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1.2

Motivation

Glioblastoma (GBM) is the most common type of glioma and the highest grade. GBM is
the type of cancer that former American Society of Clinical Oncology president George
Sledge labeled as “smart”, due to the vast mutations acquired during progression, and the
ability to rapidly invade healthy brain parenchyma.1 Advances in medical treatments have
demonstrated only minimal improvement of GBM patient’s survival. Usually, less that 5%
of the patients reach a 5-year survival milestone.2 Tumor heterogeneity, resistance to
treatment and diffuse infiltration into healthy tissue are the most relevant factors involved
in GBM resistance to treatment. Such aggressive characteristics are closely connected to
a synergistic relationship between the tumor cells and the microenvironment that allows
GBM to successfully adapt, grow and invade,
Failure to include important features of the tumor environment in early in vitro studies is
a significant consideration of why in vitro results are rarely translational to in vivo
outcomes. A critical barrier in GBM studies is the lack of in vitro platforms that
effectively represent the complexity offered by the microenvironment in terms of
dimensionality, physical, and cellular properties. Most cancer studies are performed in
liquid platforms that do not represent multi-cellular, microenvironment-mediated
responses and have limited predictive capability. Although, xenograft models have been
preferred in advanced studies to offer in vivo characteristics, their complexity limits
systematic interrogation and obstructs studies at the cellular level.
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Tissue engineering is an excellent tool that provides a multidisciplinary approach for in
vitro GBM studies. The use of tunable matrices that closely represent the main
characteristics of tumor microenvironment, such as the presence of the extracellular
matrix and stromal cells in controlled contextual situations can provide excellent
platforms to better understand GBM hallmarks such as invasion/migration, and drug
resistance.
1.3

Thesis Overview

This work focused on developing and implementing a controllable 3D in vitro platform
similar to the GBM microenvironment to bridge existent traditional models and offer
deeper insights into the overall influence of components of the microenvironment such as
extracellular matrix and presence of stromal cells on fundamental aspects of GBM such
as survival, migration and drug response.
The tumor microenvironment is a fundamental contributor to tumor initiation, proliferation,
resistance and metastasis and is comprised by three main components: the extracellular
matrix, stromal cells and tumor cells. The engineered in vitro 3D model developed

recapitulates the brain tumor microenvironment by incorporating cell-matrix and tumor
cell-stromal cell interactions as well as biophysical clues from tumor niche. By using the
model as a tool, we focused on the influence of two major components of tumor
microenvironment, namely, the extracellular matrix and stromal cells on GBM migration
and drug response. The transversal contributions result of this work that are individually
summarized as four chapters 1) An introductory background on GBM and the importance
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of the tumor microenvironment, 2) The role of the physical properties of the extracellular
matrix (ECM) during glioma migration, 3) Influence of extracellular matrix and stromal
cells presence on GBM drug-response, 4) Influence of dimensionality and presence of
stromal cells on GBM migration and 5) The effect the 3D GBM microenvironment as a
regulator of STAT3 activation and response to drug inhibition.
The first chapter presents introductory background remarks on the characteristics of
GBM, the importance of migration as a characteristic feature of GBM, the importance of
tumor microenvironment as a modulator of tumor progression and a brief overview of the
advances in the development of in vitro models that mimic the GBM microenvironment.
The second chapter sheds light onto the regulation of GBM stem cell migration
characteristics by different properties of 3D extracellular matrix (ECM) such as
composition and stiffness. The brain ECM differs from other organs in composition and
mechanical properties due to absence of rigid proteins and high presence of hyaluronan.
Given the fundamental role migration on GBM relapse, we determined how stiffness,
composition and topography of the ECM alter 3D-migration of GBM stem-like cells
(GSCs). The results revealed that GSCs exhibit different migration modes such as
collective expansion, multicellular strands, and single cell migration as a response to the
ECM composition and stiffness. The development and evaluation of a model of brain-like
ECM model showed that increasing concentrations of hyaluronan reduce migration and
presence of structural cues induce changes in migration mode of GSCs, therefore
confirming the migration plasticity of GSCs when facing a heterogeneous environment.
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The third chapter describes the influence of the microenvironment on survival of GBM
after drug treatment. We increased the complexity of our previously developed 3D model
of the GBM extracellular matrix by incorporating brain stromal cells such as astrocytes
and endothelial colony forming cells (ECFCs). The model was used as a predictor of
therapeutic response in various patient-derived GBM cell lines. Presence of the 3D
extracellular matrix decreased the cytotoxic effect of multiple drugs on GBM stem-like
cells compared to liquid culture. Also, presence of stromal cells into the 3D model
decreased the effect of single and combination drug treatment on GBM stem-like cells,
however their presence did not influence the sensitivity of non-stem GBM cells to the
same extent.

In the fourth chapter we determined the effect of presence of extracellular matrix and
stromal cells such as astrocytes and endothelial cells on GBM migration. We concluded
that presence of stromal cells in the 3D environment increases the migration of GBM
stem-like cells. However, only astrocytes and not ECFCs increase the migration of nonstem GBM cells.
The last research contribution described in Chapter 5 investigates the effect of the 3D
microenvironment on the basal activation of STAT3, a master regulator of multiple
oncogenic processes, and on STAT3 inhibition by the small molecule SH-4-54.
Preliminary results show that presence of the 3D ECM induces basal activation of
STAT3 in GBM, including cell lines that did not show basal activation when cultured in
liquid platform. Also, the presence of the 3D brain-like ECM influences the effectiveness
of STAT3 drug inhibition on reducing GBM survival and migration.
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1.4

Introductory Remarks on Glioblastoma and the Tumor Microenvironment

1.4.1

Characteristics of Glioblastoma

Glioblastoma (GBM) is a malignant astrocytoma grade IV that presents a poor prognosis
and overall median survival of 15 months.2 GBM is characterized by diffuse and rapid
infiltration across healthy brain parenchyma, neovascularization of the neighboring
microenvironment and presence of necrotic sections within the tumor mass.3 Almost
invariably GBM reappears in surrounding tissue after treatment by surgical resection,
radiation, and chemotherapy. Advances in medical treatments have demonstrated only
minimal improvement in GBM patient’s survival with less than 5% of the patients
reaching a 5-year survival milestone.2
A common characteristic of GBM tumors is the rapid neovascularization reached through
paracrine signaling with vascular endothelial cells and in some cases through direct
differentiation of GBM stem-like cells into vascular cells.4–6 GBM tumors are also
characterized by presence of a hypoxic niche as a result of rapid proliferation of tumor
cells. Although the dual presence of a perivascular and hypoxic niche seem contradictory,
hypoxic signals prompt vasculature formation, however rapid vascularization is achieved
by formation of blood vessels that provide irregular oxygen supply to the tumor, where
hypoxic sections arise.
The rapid infiltration into healthy tissue and heterogeneity of recurrent GBM have been
directly related to the presence of a subpopulation of tumor cells with stem cell-like
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features termed glioblastoma stem cells (GSCs). GSCs are classified as cells that reside in
tumor mass and share characteristics with normal neural progenitors cells such as
expression of stem markers (mainly CD133-prominin), self-renewal abilities, formation
of neurospheres, and ability to differentiate into all cells of neural origin (astrocytes,
neurons and oligodendrocytes).7 Although the concept of GSCs has been debated mainly
due to the lack of reliable set of markers, studies have demonstrated that GBM is one of
several cancer types with a relative consistent presence of cancer stem cells.8 As few as
100 GSCs CD133+ have the ability to repopulate a complete new tumor after
transplantation into a host.9
Given the tumor reappearance both, in the vicinity and in distant locations of the primary
mass, it is hypothesized that GSCs have a high migratory ability and greater intrinsic
mechanisms to resist and adapt to chemo- and radio therapy compared to non-stem GBM
cells.4,10 Moreover, the plasticity of GSCs to undergo genetic changes and differentiate
into multiple lineages cells4,6,11,12 is associated with the creation of a special niche that
harbors this population and acts as a feedback loop to provide the conditions required for
stemness maintenance. Normal neural stem cells reside mainly in specific locations of the
brain as the subventricular zone (SVZ) and the subgranular zone, that provide direct
contact with multiple cells required to support their niche, particularly, vascular networks
and mesenchymal cells.13 In a similar fashion, GSCs require specific features in their
microenvironment.

8
1.4.2

Migration as a Hallmark of Glioblastoma

Malignant gliomas as GBM present diffuse and aggressive invasion of healthy brain
tissue. GBM can successfully and rapidly invade any part of the brain, regardless of the
distance to the primary tumor, yet, unlike other cancers rarely intravasates and
metastasizes to other organs. The infrequent cases of extracranial metastasis are usually
observed in lungs, liver, lymph nodes and bone marrow and are associated with surgical
intervention of the primary mass such as biopsy and resection. Occurrence of GBM
metastasis without prior surgical intervention in the patient has been reported, however
these cases are extremely uncommon.
Successful and directional migration of GBM has been associated with the ability of the
tumor cells to recapitulate some migratory features of neural cell progenitors during
cortical development.13,14 GBM preferentially migrates along preexisting tracks such as
myelinated axons in the white matter and the basement membrane (BM) surrounding the
vasculature as histopathological examination has shown.14 This pattern of invasion
suggests the presence of productive infiltration mechanisms mediated by the brain
specific microenvironment that foster tumor expansion and are rarely present in other
organs.

9

Astrocyte
Glioblastoma

Neuron

Blood vessel

Figure 1.1 Main migration routes of glioblastoma (GBM) are axonal tracks and blood
vessels
Cell migration requires a complex coordination of multiple processes that involve
reciprocal signaling and communication with the microenvironment including the
extracellular matrix, stromal cells and other components of the tumor mass. GBM
directly

remodels

the

microenvironment

extracellular

matrix

by

depositing

glycosoaminoglycans, proteoglycans as well as other molecules that are not normally
present in neural ECM. For instance, fibrillar collagen, absent in neural ECM has been
detected in GBM both intra and extra-tumorally,15,16 suggesting its deposition by tumor
cells presumably to increase the stiffness of normal tissue as a way to facilitate migration.
Similarly, the extracellular matrix of some high-grade gliomas such as GBM presents
fibronectin, yet, similar to collagen; fibronectin is not a component of healthy brain ECM.
Fibronectin deposition has been associated with increased activity transcription factor
NF-kB in GBM cells through a process associated with uPA/uPAR activation17 and
associated with α5β1 integrin implicated in fibronectin fibrillogenesis.18 Modification of
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the extracellular matrix by glioma ultimately has the function of generating an
environment more suited for the needs of the cancer cells such as migration and adhesion.
Other components of the microenvironment such as stromal cells are also fundamental
contributors of GBM migration. Paracrine signaling between tumor cells and stroma
affect tumor migration, as has been thoroughly reviewed by Hoelzinger (2007) and
Placone (2016). Additionally, recent studies have shown that microglia, the brain resident
macrophages, contribute to tumor migration by both, increasing GBM expression of
matrix metalloproteinases such as MMP-219 and secreting pro-inflammatory cytokine IL18.20 Secretion of glial-derived neurotrophic factor (GDNF)21 and TGF-β by astrocytes
triggered by interaction with tumor cells has also been shown to increase GBM migration.
Beyond the widely studied role of paracrine signaling GBM migration, physical contact
between tumor and stroma also has a profound impact on the ability of tumor cells to
successfully migrate. Physical interaction between tumor cells and vasculature in a
process denominated vessel cooption is one of the earliest mechanism by which the
tumor cells reach “vascular highways” to migrate. During co-option GBM cells target
pericytes on the existing vessels by developing specialized protrusions called flectopodia.
The physical communication established between the two cell populations is transient
and occurs prior tumor neovascularization.22 Similarly, increased expression of the gap
junction protein connexin-43 in glioma cells has been linked to increased migration
mediated by intercellular gap junction communication between the tumor and astrocytes
as well as intercellular transference of microRNA-5096 and microRNA-4519, both
implicated in tumor migration.23,24
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The relationship between migration and microenvironment is reciprocal and dynamic.
Along with interactions tumor-stroma and the effect of glioma on remodeling the
extracellular matrix, the existing microenvironment also modulates the migration
strategies adopted by cells. The adaption of cancer cell migration mode in response to
different microenvironments has mainly been observed in 3D in vitro constructs.
Observations of breast cancer cells switching from collective spheroids in basement
membrane-like matrices to mesenchymal single migration in collagen matrices25 or GSCs
switching from single cell migration in collagen to a multicellular stream migration when
faced with topographical clues that mimic blood vessels26 are examples of the influence
of the physical microenvironment on motility. Despite great advances understanding the
influence of diverse physical cues on migration, how biological and physical factors
interplay to determine a preferential migration strategy remains to be understood.
Previous studies have linked the ECM properties like matrix elasticity with the
polarization of regulators of cell migration such as Rho family GTPases. Petrie (2012)
showed that elastic behavior of the ECM, induces specific polarization patterns of the
Rho GTPases Rac1 and Cdc42 governed by RhoA, ROCK or myosin II activity.27
Recently, Mertsch (2013, 2014)28,29 showed that ROCK1 mediates substrate-dependent
GBM migration and its inhibition decreases the ability of GBM to recognize different
types of ECM and show preferences for specific ECMs to migrate.
The specific role of the multiple physical and chemical signals that the brain
microenvironment provides to brain tumors (and vice versa) to trigger migration is still in
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its infancy. However, elucidating such interactions is fundamental to understand the
dynamics of brain cancer progression.

1.4.3

Role of the Tumor Microenvironment in Glioblastoma Progression

The influence of the microenvironment as a regulator of cell response has been
increasingly recognized. Cell behavior is not only dependent of genetic instructions but is
equally modeled by the external signals from the microenvironment. Specifically in
cancer, such regulation reaches a higher level of complexity and reciprocity due to the
active remodeling exerted by the cancer cells on the microenvironment. Cancer cells
modify factors such as pH and nutrients availability and recruit supporting stromal cells30
to recreate a new niche commonly referred as tumor microenvironment that works as a
support network to foster tumor survival and resistance. Tumor microenvironment is
comprised by three main components: tumor cells, extracellular matrix and surrounding
stromal cells.

Figure 1.2 Components of the glioblastoma tumor microenvironment. Other cells native
to brain tiusse and also associated to the tumor microenvironment such as
oligodendrocytes, neurons, pericytes, microglia and others are not depicted.
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The normal brain microenvironment presents distinctive characteristics compared to the
majority of other tissues. Brain ECM is a low stiffness, loosely connected network
mainly comprised of hyaluronan, a non-sulphated glycosoaminoglycan with high waterbinding capacity, proteoglycans and Tenascin R and has no presence of rigid proteins
such as type I collagen or fibronectin.31 Other fundamental differences of brain
microenvironment that contribute to the uniqueness of brain cancers as GBM are: the
presence of a different immune defense comprised mainly by microglia, that is also
recruited to help tumor survival,32 and the existence of the blood brain barrier (BBB),
formed by astrocytic end-feet lining the surface of the blood vessels, which prevents
larger, hydrophilic or large molecules including chemotherapy agents to successfully
reach the brain parenchyma.33 Additional to the unique features of brain ECM, GBM
dynamically remodels the native ECM to better suit the needs of the tumor during
progression generating an extracellular matrix distinctive to the tumor that differs in
composition and mechanical properties to the healthy brain ECM.

Stromal cells present on the surrounding or specifically recruited by the tumor are
another important component of the tumor microenvironment and well-established
modulators of cancer growth. One of the most studied stromal cells present in GBM
microenvironment are endothelial cells, recruited by GBM to vascularize the tumor and
contribute to both, maintenance and invasion.4,7,34 Endothelial cells are recruited by GBM
though a mechanism that involves the generation of a hypoxic niche, product of rapid and
uncontrolled tumor proliferation, that releases proangiogenic signals and triggers the
formation of new vasculature to supply the tumor.35–37New blood vessels present not only
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a source of nutrients and oxygen but also a permissive route that guides migration and
enhances the development of distant satellite tumors.
Likewise, astrocytes and microglia are important players during formation of GBM
microenvironment. Astrocytes are the main non-neuronal cell of the brain and comprise
nearly 50% of brain total volume.38 Presence of GBM cells have shown to induce
astrogliosis in astrocytes adjacent to the tumor,38–40 by a process that recapitulates the
astrocytic response to brain injury. Astrogliosis induced secretion of pro-inflammatory
signals supports GBM migration and proliferation and acts as a protection barrier to
immune surveillance, mainly by T-cells.41
Microglia are the immune cell residents of brain and account for nearly 10-20% of all the
brain glia population. After injury or damage, microglia acquire an “activated phenotype”
that corresponds to increase proliferation, migration, cytokine release and production of
oxygen reactive species.42 During formation of GBM microenvironment microglia
heavily infiltrate the tumor mass and despite their role as macrophages do not contribute
to reduce the tumor progression as it was initially hypothesized. Instead, an increasing
number of studies suggest that microglia resident in the tumor microenvironment
contribute to tumor maintenance and immune response suppression.42 Tumor associated
microglia can help ECM remodeling and tumor migration by secretion of matrix
metalloproteinases and growth factors. Yet, tumor resident microglia have a reduced
ability to induce anti-tumor T-cell response, likely due to tumor repression of microglia
pro-immune processes as antigen presentation, phagocytosis inflammatory signals
release.42
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Finally, the third component of the tumor microenvironment are the tumor cells, and despite
the plain relationship of tumor cells with the tumor microenvironment, is important to note
that the heterogeneity of many GBM tumors and dynamic changes in tumor population are
fundamental for the constant remodeling of the tumor microenvironment. The rapid
development of new satellite tumors in GBM and resistant to treatment has directly related to
the presence of a subpopulation of tumor cells with stem cell-like features termed
glioblastoma stem cells (GSCs). GSCs are classified as cells from the tumor mass that share
characteristics with normal neural stem cells such as expression of stem markers (mainly
CD133-prominin), self-renewal abilities, formation of neurospheres, and ability to
differentiate into all cells of neural origin (astrocytes, neurons or oligodendrocytes).7
Although the concept of GSCs has been debated based on the lack of a reliable set of markers,
studies have demonstrated that GBM is one of several cancer types with a relative consistent
presence of cancer stem cells.8 As few as 100 GSCs CD133+ have the ability to repopulate a
complete new tumor after transplantation into a host.9
Given the appearance of new tumors both, in the vicinity and in distant locations of the
primary mass, it is hypothesized that GSCs have a high migratory ability and greater intrinsic
mechanisms to resist and adapt to chemo- and radiotherapy compared to non-stem GBM
cells.4,10 Moreover, the plasticity of GSCs to undergo genetic changes and differentiate into
multiple lineages cells4,6,11,12 is associated with the creation of a special niches with the tumor
microenvironment that harbor this population and acts as a feedback loop to provide the
conditions required for stemness maintenance. In a similar fashion to neural stem progenitors,
GSCs are thought to reside in locations similar to subventricular zone (SVZ) and the
subgranular zone that provide direct contact with multiple cells required to support their
niche, particularly, vascular networks and mesenchymal cells. 13
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GSCs require specific features in their microenvironment. A common characteristic of GBM
tumors with presence of GSCs is the presence of a perivascular niche reached. Such vascular
niche is product of the rapid neovascularization triggered by recruitment of vascular
endothelial cells and in some cases by GSCs differentiation into vascular forming cells.4–6
Tumor presenting GSCs also can contain a hypoxic niche as a result of rapid proliferation.
Although the concomitant presence of a perivascular and hypoxic niche might seem
contradictory, hypoxic signals prompt vasculature formation; yet, the rapid vascularization of
the tumor results in leaking blood vessels and irregular oxygen supply giving rise to hypoxic
sections within the tumor.
Given the reciprocal relationship between the tumor and its microenvironment, understanding
GBM not as a sole aggregation of cells with certain genetic mutations but as a self-regulating
entity comprised by multiple factors besides the tumor cells might offer new directions to
target more effectively this disease.

1.4.4

3D in vitro Models of Glioblastoma Microenvironment

Regular studies of GBM are typically performed using 2D monolayer culture on surfaces
such as glass or plastic, sometimes pretreated poly-l-lysine to increase cell adhesion or
covered with a thin layer of collagen or laminin to incorporate certain components of the
extracellular matrix during tumor culture. Studies using 2D liquid culture have
contributed with seminal results in the overall understanding of GBM; yet, liquid culture
has restricted versatility in terms of recapitulating the physiological features of the tumor
microenvironment. One critical drawback of liquid culture to be used in tumor
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microenvironment studies is the effect of a rigid planar surface on cell movement. First,
because planar surfaces restrict the motility of cells to two dimensions and second,
because allow the development of cell contacts with a substrate that much more rigidity
and stiffness than any brain region. During 2D culture cells have a rapid and
homogeneous accessibility to nutrients in the media. Contrastingly, in real tissues the
presence of a 3D ECM generates a gradient of nutrients and oxygen that modulates tumor
processes such as proliferation and recruitment of stromal cells.
Motivated by the need of better models to recapitulate the physiological conditions of
GBM microenvironment, various authors have approached the generation of 3D culture
platforms to recapitulate in vitro the GBM microenvironment. However, most of these
studies have focused solely on the interaction glioma-ECM overlooking the importance
of tumor-stroma interactions.
Diverse approaches have been developed to better simulate the tumor and tumor
microenvironment, and can be classified into two main groups: scaffold-based and
spheroid liquid-based 3D models. Controversy exists as to which recapitulates more
precisely in vivo settings; yet, both approaches have advantages and disadvantages
depending on the type of study performed. A combination of both, spheroids in scaffoldbased platforms seem to be one of the best approaches, but can difficult the convenience
for high-throughput studies.
Initial studies of GBM in 3D platforms were performed in collagen I or Matrigel matrices,
however, a main drawback of in these models was the lack of similar composition to the
extracellular matrix of glioma tumors as this is mainly comprised by hyaluronan. To
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incorporate hyaluronan, Ananthanarayanan (2011)43 and Pedron (2013)44 developed
chemically functionalized hyaluronan (HA) matrices to study GBM. Their data reflect
similar responses to in vivo studies; yet, to achieve a crosslinking matrix, hyaluronan
needs to be chemically modified and such modifications naturally absent in vivo can alter
tumor-ECM interaction. Similarly, as a attempt to better recapitulate the presence of
hyaluronan in glioma 3D models, Yang (2011)45 and Rao (2013)46 generated collagenHA matrices, however, these studies used pepsin-treated collagen, a collagen that have
lost the collagen telopeptides required to form covalent crosslinks and therefore does not
reflect the architecture and mechanical properties of in vivo structures.45–47
New approaches to better mimic GBM microenvironment need to be developed. The
work presented here aims to contribute to the field by introducing a tunable 3D model
that recapitulates the composition of the GBM microenvironment and also incorporates
stromal cell populations to generate a model physiologically more relevant for in vitro
studies.
Still, many challenges lie ahead in order to have a better approximation the in vivo tumor
microenvironment. Among the more relevant tasks is the incorporation of tissue
compositional and physical heterogeneities present in different regions of the brain. Also,
the ability to generate a model with similar cell density and number of cell types as the
tumor microenvironment as well as cell-ECM ratio similar to native tissues. Currently,
3D matrices present limitations in the cell number possible to incorporate due the matrix
retraction and deformation caused by cell forces. The use of spheroids within 3D ECM as
structures dimensionally similar to the tumor mass has several advantages especially in
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the formation of oxygen and nutrient gradients. Nevertheless, accurate assessment of
metabolic rate and survival can be challenging in these models especially in the event of
using these models as high-throughput platforms for drug analysis.
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CHAPTER 2. GRATION OF GLIOBLASTOMA STEM CELLS IS MODULATED BY
THE PROPERTIES OF THE EXTRACELLULAR MATRIX

2.1

Introduction

Glioblastoma (GBM) is a highly invasive and lethal brain cancer. GBM resistance, rapid
growth and propagation have been linked to the presence of a subpopulation of tumor
cells with stem cell-like features termed glioblastoma stem cells (GSCs).8,48–52 Given the
aggressiveness of GSCs, it has been hypothesized that these cells drive the invasion into
healthy brain tissue and contribute to regrowth of a new heterogeneous tumor.

It is now well established that tumor cell invasion and maintenance of tumor stem cells
are processes regulated by the microenvironment and involve specific interactions with
the extracellular matrix (ECM).53–55 Healthy brain ECM has a distinct composition
relative to other tissues and organs. It represents a low stiffness, loosely connected
network comprised mainly of hyaluronan.31,56 In cases such as glioma development,
tumor cells actively remodel their microenvironment by depositing its own ECM,
including type-I collagen as a component of the tumor tissue, the surrounding peritumoral
environment,15 and the GSCs niche.57 GBM can successfully invade any part of the brain,
yet, unlike other cancers rarely metastasizes to other organs. During invasion, migratory
GBM cells preferentially use existing tracks such as myelinated axons in the white
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matter and basement membrane (BM) surrounding blood vessels.14 Such specific
invasion pattern suggests the existence of productive infiltration mechanisms mediated by
the brain specific microenvironment that foster tumor expansion.31,58

Despite the well-known characteristics of brain microenvironment and glioma invasion
routes, there is still a lack of understanding about the mechanistic migration processes
exhibited by GBM cells and specifically by GSCs.59 A critical barrier in the cancer field
is that most of the invasion and migration studies are conducted using 2D substrates that
fail to recapitulate the dimensionality, composition and physical properties of brain
tissue.60 Consequently, 3D in vitro models that mimic multiple features of the tumor
microenvironment and allow the study of important cancer cell subpopulations such as
GSCs, are required to complement in vivo models and histopathological analysis.

In this study we recreated the one of main features of the GBM microenvironment, the
extracellular matrix, by developing a tunable 3D matrix with similar composition to
GBM ECM with incorporated topographical tracks that simulate the brain vasculature, to
study over time the migratory behavior of GSC neurospheres by using the GBAM1
(CD133+) cell line. The composite matrix consisted of a hyaluronan network structurally
supported by a customizable collagen-oligomer fibril matrix embedded with BM-coated
microfibers to provide alternative migratory paths as occurs in vivo. For comparison, we
generated reconstituted matrices from the most common 3D cell culture substrates, type-I
collagen monomers and Matrigel. To account for differences in molecular composition
and fibril-matrix formation capacity of different type-I collagen formulations, we
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prepared matrices with diverse structural and mechanical properties using commercial
monomeric collagen (BD Biosciences), atelocollagen and oligomeric collagen. We
cultured the GSCs (GBAM1) neurospheres in the different matrices and monitor
overtime how fundamental migratory behavior such as migration mode, velocity,
maximum distance and morphology exhibited by GSC neurospheres was regulated by the
compositional and physical properties of the different matrices.

2.2

2.2.1

Experimental Section

Maintenance of GBM cell line

GBM cells isolated from human surgical tumor specimens sorted by FACS for CD133
expression (GBAM1) were kindly provided by Dr. Phillip Tofilon and the Moffitt Cancer
Center. GBAM1 cells were maintained in stem liquid media DMEM/F12 supplemented
with B27 without vitamin A (Life Technologies, Carlsbad, CA) and with growth factors
EGF, bFGF (50 ng/ml each, Peprotech, Rocky hill, NJ), at 37°C in an atmosphere of 5%
CO2. Cells were propagated in T25 or T75 flasks and fed with complete media every
other day. Neurospheres were disaggregated with TrypLE (Life Technologies, Carlsbad,
CA) and passaged every 7 days.
2.2.2

Synthesis of collagen matrix

3D collagen matrices were generated using rat tail type-I collagen monomers from BD
Biosciences (San Jose, CA), pig skin type-I collagen oligomer,61 and pig skin type-I
atelocollagen. All collagens were adjusted to desired concentration and polymerized by
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neutralization with 10X PBS (1X PBS has a 0.17M total ionic strength) and 0.1N sodium
hydroxide to reach pH 7.4. During and after neutralization all reagents were maintained
at 4°C, the neutralized collagen solutions were pipetted at volumes of 100 µl in 96 multiwell plates and polymerized at 37°C during 30 min.

2.2.3

Development of a brain-like extracellular matrix

To generate the composed oligomer-hyaluronan matrices, sodium hyaluronate of
molecular weight between 351-600 KDa (Lifecore Biomedical, Chaska, MN) was
dissolved in 10X PBS and added during neutralization of the oligomer to attain final
concentrations of 2 mg/ml oligomer and 2, 5 and 10 mg/ml hyaluronan. To mimic the
topography generated by the blood vessels in the brain parenchyma, pseudo-vessels were
recreated using sterile rods of PDS II- polydioxanone of diameter 100-150 µm (Ethicon,
Blue Ash, OH) coated with Matrigel by immersion. The coated rods were incubated at
37°C for 30 min and immersed in the oligomer-hyaluronan matrix prior polymerization.

2.2.4

Cell culture in 3D matrices

GBAM1 cells were cultured in complete liquid media for 4 days. Neurospheres were
embedded in each of the matrices (Matrigel from BD Biosciences, collagen and collagenhyaluronan) prior polymerization to achieve a density of 1-2 neurospheres per 100 µl of
polymeric suspension. Volumes of 100 µl of cell-matrix suspension were platted into 96
well plates. The matrices were polymerized at 37°C for 30 minutes and 100 µl of
complete liquid media was added. Cells were cultured at 37°C in an atmosphere of 5%
CO2.
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2.2.5 Analysis of mechanical properties
Rheological properties of the matrices were measured by oscillatory shear in a stresscontrolled AR2000 rheometer (TA Instruments, New Castle, DE, USA) using a parallel
plate geometry (40 mm diameter). Each sample (1 ml) was polymerized at 37°C on the
rheometer during 30 min, the geometry was set at 725 µm gap distance and humidity was
maintained by a solvent trap as previously described.61 The viscoelastic properties, shear
storage modulus (G’) and shear loss modulus (G’’) were determined by a strain-stress
sweep from 0.01 to 0.4% at 1 Hz (this range was chosen from predetermined linearviscoelastic response regions). All measurements were conducted on at least three
independent samples.

2.2.6

Immunofluorescence staining

For detection of N-cadherin in Matrigel matrices, neurospheres were fixed with 4%
glutaraldehyde, permeabilized with 0.5% triton X-100 (Sigma-Aldrich, St. Louis, MO),
blocked with 5% BSA (Life Technologies, Carlsbad, CA) in PBS and incubated with
primary N-cadherin antibody (Santa Cruz Biotech, Santa Cruz, CA) (dilution 1:40) at
4°C for 12 h followed by washing and incubation with secondary antibody tagged to
Alexa-488 (Life Technologies, Carlsbad, CA) (dilution 1:200) at 4°C for 6 h. Nuclei
were counterstained with Hoechst 33342 (Life Technologies, Carlsbad, CA).
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2.2.7

Laser scanning confocal and light microscopy

Images of neurospheres were taken every 24 h during 3 days using bright field and phase
contrast in a CKX41 Olympus inverted microscope. All images were collected using an
AmScope (10MP) camera. Confocal microscopy was performed using a Nikon A1R-MP
confocal microscope with objectives Apo 40X (1.25 NA) and Plan Fluor 40X-oil (1.3
NA). Confocal reflectance microscopy was performed to analyze the structure of the
collagen-hyaluronan matrices in their hydrated state. The images were obtained from
three independent samples for each matrix at random positions using the objective Plan
Fluor 20X (0.75 NA) in reflectance mode.

2.2.8

Analysis of morphology and migration

Bright field and phase contrast images were analyzed using the software ImageJ (NIH,
Bethesda, MD). Migration distance was quantified as the distance from the initial
perimeter of the neurosphere to the edge of the most external protrusion or migratory
cell.47,62 Average migration velocity was calculated by dividing the distance recorded by
the time interval chosen (24, 48 or 72 h).

2.2.9

Statistical analysis

Quantitative data were compared by t-test (α=0.05), Mann-Whitney or ANOVA using the
statistical software package SAS 9.3 (SAS Institute, Cary NC).
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2.3

2.3.1

Results

GBAM1 presents stem-like characteristics

GBAM1 human patient-derived cells were previously sorted and isolated for CD133+
expression. To corroborate that the cells met all criteria to be considered a stem-like
population9 we tested the formation of neurospheres during liquid standard culture,
expression of the stem-like markers and ability to differentiate into glial cells. GBAM1
cultured in liquid platform formed non-adherent neurospheres in all stages of culture (Fig
2.1 A).

A

B

Figure 2.1 A. GBAM1 form non-adherent neurospheres in liquid culture. Bars 200 µm. B
GBAM1 differentiate after 15 days of culture in differentiation medium. Bars 100 µm.

Immunofluorescence staining showed that neurospheres expressed the stem markers
Sox2, Notch, and CD133+ and did not express the standard marker for reactive astrocytes
GFAP (Fig 2.2 A). Contrary to GBAM1, human astrocytes did not express any of the
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stem-markers, but expressed GFAP (Fig 2.2 B). Evaluation of the ability of GBAM1 to
differentiate into glial cells after deprivation of growth factors and addition of FBS,
resulted in visible morphological change, and gaining of adherence, all characteristics of
differentiated brain cells in liquid culture (Fig 2.1 B).

Figure 2.2 A. GBAM1 neurospheres (passages 17-23) exhibit markers of GBM cancer
stem-like cells (CD133, Sox2 and Nestin) after 5 days of liquid culture. GFAP marker for
differentiated astrocytes is not expressed. B. Human primary astrocytes do not express
stem-like markers (CD133, Sox2 and Nestin), but are positive for GFAP expression. Bars
100 µm.

28
2.3.2

Modulation of GSC migration by Matrigel characteristics

Invasion of cancer cells has been traditionally studied in Matrigel matrices due to its
similar composition to the basement membrane (BM), an in vivo type of ECM used by
cancer cells for invasion.55,63 To investigate the migration of GSCs in matrices of similar
composition to BM, neurospheres were seeded in Matrigel (100%), Matrigel (75%)DMEM/F12 (25% v/v) and Matrigel (50%)-DMEM/F12 (50% v/v) to monitor migration.
During the first 24h neurospheres developed thin pseudopodia-like extensions that were
more abundant and larger in Matrigel 50% compared to other Matrigel matrices.
Subsequently, the extensions exhibited in Matrigel 75% and 100% disappeared, and cells
continued expanding as a functional aggregate with spherical morphology resembling
multicellular migration by expansive growth (Fig. 2.3).(33) Contrastingly, the initial
pseudopodia developed in Matrigel 50% extensions were gradually replaced by large and
wide protrusions with elongated tips that grew radially and remained in contact with the
neurosphere.
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Figure 2.3 GSC neurospheres present different migration characteristics when seeded
within Matrigel matrices of different concentration. Neurospheres exhibit migration by
expansive growth when cultured in 3D matrices of Matrigel 100% and 75%, while in
Matrigel 50% exhibit multicellular strand migration due to low stiffness of the matrix
(semi-3D substrate). Bars 100 µm. Migration was determined as the distance from the
initial perimeter of the neurosphere to the edge of the most external strand or migratory
cell.
3D reconstruction from confocal microscopy images of neurospheres cultured in Matrigel
50% showed that the tips of the migratory strands were located on the same focal plane
(Fig 2.4 A) suggesting that in contrast to the other 3D matrices, Matrigel 50% allowed
the generation of focal contacts with the plate surface generating a semi-3D (or 2.5D)
substrate.64 It is possible at this Matrigel concentration, the material shear storage
modulus became low enough (Table 2.1) for the neurospheres to settle and interact with
the rigid surface of the 2D culture plate.
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Table 2.1 Viscoelastic properties of the different matrices used for 3D migration studies
of GSCs (n=3), mean ± SEM.
Matrix
Matrigel 100%
Matrigel 75%
Matrigel 50%
Oligomer 3 mg/ml
Oligomer 2 mg/ml
Oligomer 1.5
mg/ml

Shear storage
modulus G' (Pa)
56.5 ± 3.1
35.6 ± 0.8
17.9 ± 0.3
885 ± 92.3
397 ± 32.7

Matrix

Shear storage
modulus G' (Pa)
24.5 ± 0.3
6.5 ± 1.9
39 ± 2.1
4 ± 1.3
126.2 ± 14.6

BD-Col 3 mg/ml
BD-Col 1.5 mg/ml
Atelocollagen 4 mg/ml
Atelocollagen 2 mg/ml
HA:2 mg/ml-Col:2 mg/ml
HA:5 mg/ml -Col:2
107.9 ± 19.6
225 ± 14.1
mg/ml
HA:10 mg/ml -Col:2
Oligomer 1 mg/ml
36.1 ± 0.6
90 ± 5.2
mg/ml
Note: Stiffness of normal brain tissue ranges between 260-500 Pa.65 Although
given the heterogeneity of the organ there can be sections with lower of higher
values.
To corroborate that multiple cells in contact formed the extensions we performed
immunostaining to detect expression of N-cadherin. The results suggest maintenance of
cell-cell contacts in both, the cells forming the neurosphere and the cells migrating as
multicellular extensions (Fig 2.4 B). In comparison, GSCs in 3D Matrigel expanded into
significantly smaller distances and with significantly slower velocities compared to the
GSCs that were able to contact the rigid culture plate.

31
A

B

Figure 2.4 A. Z-reconstruction of GSCs migrating in Matrigel 50% after 24 h shows that
collective migrating extensions are located in the same focal plane. B. GSCs cultured in
Matrigel 50% develop contacts with rigid surfaces of the plate (semi-3D substrate) giving
onset to wide, stable and long protrusions comprised of one or more cells with intact and
stable cell-cell contacts. Neurospheres after 72h of culture were fixed and stained with
Hoechst 33342 and N-cadherin-Alexa 488. Staining for nuclei was incomplete due to the
high density of the neurosphere. Bars 25 µm

2.3.3

Type-I collagen matrices support single cell migration of GSCs regardless of
collagen concentration or formulation

Fibrillar collagens are ubiquitous components of the ECM in the majority of tissues and
organs and have been demonstrated to be present within glioma tissues and its
surrounding ECM during tumor progression.16 To further explore the morphology and
migration characteristic of GSCs, type-I collagen matrices with diverse characteristics
were generated using type-I oligomers (Oli) isolated via acid-solubilization of pig skin,
type-I atelocollagen from pepsin-treated pig skin (Atelo), and BD-Biosciences type-I
collagen from rat tail (BD). Migration of GSCs in all collagen matrices occurred by
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single cell migration (Fig 2.5) consistent with the migration mode presented by other
glioma cells in commercial collagen.47,62 Different concentration of collagen, absence of
telopeptides (atelocollagen), or collagen source (commercial rat tail or pig skin) did not
modulate the migration mode exhibited. Neurospheres cultured in collagen developed
thin pseudopodia–like extensions with subsequent detachment of single cells from the
neurosphere. Migration occurred in all directions with cells presenting a spindle-shape
morphology resembling mesenchymal single-cell migration (Fig 2.5).

BD-Col 3 mg/ml Oligomer 3mg/ml Oligomer 1mg/ml BD-Col 1.5mg/ml Oligomer 1.5mg/ml
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Figure 2.5 GSC neurospheres embedded in multiple types of collagen type-I matrices
present single cell migration mode. Bars 100 µm.

2.3.4

Collagen formulation and concentration influence migration distance and velocity
of GSCs

Parameters such as collagen source, isolation method, and polymerization reaction
conditions dictate the mechanical and physical properties of self-assembled collagen
matrices61 and are expected to affect migration distance and velocity. While previous
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studies have explored glioma migration in collagen, only standard commercial
monomeric collagen was used to generate 3D matrices.46,47,62 Unlike conventional
monomer matrices, which represent entanglements of long fibrils, oligomers induce
interfibril associations to yield branched fibril networks. Here, collagen matrices were
prepared at concentrations ranging from 1-4 mg/ml, and GSCs migration distance and
velocity were measured as a function of concentration, formulation and matrix stiffness.

Variation of collagen concentration affected the migration velocity of GSCs (Fig 2.6).
The relationship between concentration and velocity was specific for each of the collagen
formulations. Atelocollagen matrices, prepared from collagen molecules in which
telopeptide regions have been enzymatically eliminated showed short migration distances
and low matrix stiffness values (Fig 2.7 Table 2.1) along with low velocities that slightly
increased with concentration (Fig 2.6). BD-collagen matrices also exhibited low stiffness
and induced slightly higher although non-statistically different levels of invasion
compared to atelocollagen. However, the velocity decreased moderately as the collagen
concentration increased (Fig 2.6). In contrast to other formulations, oligomer presented
the highest stiffness at the same fibril density (Fig 2.7 Table 2.1) and a broad range of
migration distances as a function of collagen concentration.
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Figure 2.6 BD1.5 (BD-Col 1.5 mg/ml), Oli (oligomer), Ate (atelocollagen). The highest
velocity was reached in Oligomer 1.5 mg/ml and Oligomer 2 mg/ml, 2 mg/ml. Maximum
velocity was reached during the first 24 h of culture and decreased subsequently. Values
marked as * are statistically different from ** p-value<0.05, † are statistically different
from †† p-value<0.05. n=9 (Oligomer), n>4 (BD-Col and atelocollagen), error bars
indicate ± SEM

The velocity and distance increased with oligomer concentration until reaching a
maximum in 2 mg/ml matrices, subsequently, velocity and distance decreased for
matrices of higher concentration (3 mg/ml) (Fig 2.6). Interestingly, matrices such as BDCol and Ate that represented the low-end of the matrix stiffness spectrum (4-39 Pa)
supported low migration distances and velocities similar to those obtained in matrices as
Oli-3 that represented the highest matrix stiffness (885 Pa) evaluated and exhibit higher
cell-matrix contacts but reduced porosity. Analysis of oligomer matrices encompassing a
wider range of stiffness values (90–885 Pa) suggested an optimum range where the
maximum migration is reached (Fig 2.7). GSCs cultured within matrices Oli-1.5 and Oli2 (225-397 Pa) of similar stiffness values to brain tissue (260-500 Pa)65 supported the
greatest migration.
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Figure 2.7 Optimal migration velocity of GSCs in collagen-I occurs at stiffness levels in
the range found in normal brain (represented in green section).65 Values marked as * are
statistically different from **, † are statistically different from ††, p-value<0.05.
Oligomer matrices with G’ of 225 Pa (Oligomer 1.5 mg/ml) and 397 Pa (Oligomer 2.0
mg/ml) supported the greatest migration distance and velocity compared to other collagen
matrices. Error bars indicate ± SEM

2.3.5

Presence of hyaluronan in composite matrices reduces GSC migration

To recreate some essential features of glioma ECM composition and study the migratory
behavior of GSCs, composite matrices of hyaluronan (HA) and type-I collagen (Col)
were generated with 0, 2, 5, and 10 mg/ml of HA and a constant oligomer concentration
of 2 mg/ml. GSC neurospheres cultured in Col-HA matrices exhibited early pseudopodia
extension followed by single cell migration similar to what was observed in collagenonly matrices. Nevertheless, increasing hyaluronan concentration proportionally reduced
migration as well as the frequency of cell detachment from the neurospheres (Fig 2.8
A,B). Cells cultured in Oligomer 2 mg/ml exhibited the greatest migration distance, while
cells in HA:2-Col:5 mg/ml and HA:2-Col:5 mg/ml presented a significant reduction of
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migration compared to only oligomer matrices. The most drastic reduction was observed
in HA:10-Col:2 mg/ml where very few cells detached from the neurosphere and migrated
considerable short distances. Cells that left the neurosphere were able to increase the
migration velocity over time different to what was observed for the other matrices (Fig
2.8 C). Additionally, presence of HA induced morphological changes of the migratory
cells. Cells switched from an elongated morphology observed in the only-oligomer and
HA:2-Col:2 mg/ml matrices, to a mixed population of elongated and rounded cells in
HA:5-Col:2 mg/ml matrices, and to a mostly rounded morphology in HA:10-Col:2 mg/ml
matrices.
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Figure 2.8 A. GSCs present single cell migration in composite Oligomer-hyaluronan
matrices similar to only-oligomer matrices. Increasing concentration of hyaluronan
decreases the number of migrating cells and alters the morphology of the migratory cells
from elongated to spherical shape. White arrows point out elongated migrating cells,
black arrows point out rounded migrating cells. Bars 100 µm B. Distance of migration is
reduced with increasing presence of HA. All matrices present statistically different
distance at all time points excepting HA:2-Col:2 and HA:5-Col:2 mg/ml C. Velocity
decreased with time as observed with other matrix types, except HA:10-Col:2 mg/ml
matrix where the velocity increased with time. Values marked as * are statistically
different from ** p-value<0.05, † are statistically different from †† p-value<0.05, #, ##
and ### are statistically different p-value<0.05. n=9, error bars indicate ± SEM.

2.3.6

Addition of hyaluronan modulates fibril microstructure and mechanical properties
of oligomer matrices

To further analyze how the incorporation of hyaluronan altered the mechanical properties
of the matrices and the migratory behavior of GSCs, we performed viscoelastic shear
tests of the composite matrices. Increasing HA concentration reduced the storage and loss
moduli while slightly decreasing the phase angle (δ) of the matrix (Table 2.2). The
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greater values of the storage modulus compared to the loss modulus, indicate that the
matrix dynamic response is mainly controlled by the elastic (solid) phase. Structural
changes of the matrix caused by HA were examined by confocal reflectance microscopy
(CRM) and suggest that hyaluronan incorporation does not affect fibril density, as was
expected for matrices of the same collagen concentration, but disrupts the formation of
interfibril associations reducing the fibril branching (Fig 2.8). Since collagen fibril
branching is correlated with matrix stiffness,66 the reduction of fibril associations caused
by HA might have contributed to stiffness reduction.

Table 2.2 Viscoelastic properties of the composite matrices of oligomer collagen and
hyaluronan (n=3), mean ± SEM. HA: hyaluronan.
Matrix
HA:2-Col:2 mg/ml
HA:5-Col:2 mg/ml
HA:10-Col:2 mg/ml

Viscoelastic Properties
G' (Pa)
G'' (Pa) δ (degrees)
126.2 ± 14.6 15.8 ± 0.4
7.2 ± 0.1
107.9 ± 19.6
13.4 ± 2.2
7.1 ± 0.1
36.1 ± 0.6
3.7 ± 0.1
5.9 ± 0.0

Figure 2.9 Confocal reflectance microscopy of oligomer matrices with varied
concentration of hyaluronan. Hyaluronan presence altered the collagen interfibril
associations. Bars 50 µm.
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2.3.7

Glioblastoma stem cells (GSCs) exhibit multiple migration modes

We next asked what would be the overall migratory response of GSCs in a 3D in vitro
microenvironment that mimics the composition and topography of the glioma
environment in a single 3D construct. To address this question we cultured GSC
neurospheres in a composite matrix of HA:10-Col:2 mg/ml with embedded Matrigel
coated microfibers to imitate the structural tracts formed by the blood vessels thereby
providing the cells diverse migratory paths. We observed that neurospheres located close
to the fibers migrated towards the fiber and developed strand collective migration using
the topographical cues as physical support (Fig 2.10 A). Cells migrating along the rods
maintained cell-cell contacts during movement as was identified by the expression of Ncadherin and did not separate from the neurospheres, whereas cells facing the collagenhyaluronan matrix directly (no rods nearby) detached from the neurosphere and exhibited
single cell migration as was observed previously in only-collagen and collagenhyaluronan matrices.
The velocity and maximum distance for collective migration along the rods (Fig 2.10 B,
C) were comparable with the values obtained for single cell migration in oligomer 2
mg/ml matrices and are greater than the values obtained for migration in oligomerhyaluronan matrices. The results indicate that multicellular strand migration exhibited
during durotaxis, such as along the structural cues in composite matrices and in the semi3D (Matrigel 50%) matrix, is the most productive and fastest migration mode as it favors
the generation of combined motility force, and maintains important paracrine signaling.53
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Figure 2.10 A. GSC neurospheres exhibited multiple migration modes in composite
matrix as single cell migration mode across the 3D matrix and collective strand migration
along the topographical cues present in the matrix. Immunofluorescence was used to
detect N-cadherin. N-cadherin appears in green and nuclei in blue. Staining for nuclei
was incomplete due to the density of the neurosphere. Bars 100 µm. B. Distance of
migration along the rods increases with time and presents values comparable to those
obtained during migration in Matrigel 50%. N=4, error bars indicate ± SEM. C. Velocity
of migration along the rods slowly decreases with time presenting values comparable
with other types of matrices such as Oligomer 2 mg/ml, n=4, error bars indicate ± SEM.
D. Comparison of GSCs maximum distance of migration in different types of matrices at
72 hours, n=9. E. Comparison of GSCs velocity of migration in different types of
matrices at 24 hours, n=9.
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2.4

Discussion

Migration of glioblastoma stem cells (GSCs) has been linked to post-operative tumor
recurrence. Nevertheless, the migratory characteristics of this cell population in diverse
types of extracellular matrices, has not been previously studied in detail. Here, we used
multiple 3D formats commonly used for tumor invasion studies such as Matrigel and
type-I collagen as well as a novel composite in vitro model that mimics the ECM
composition, physical properties, and topography of glioma microenvironment. Our
results indicate that GSCs exhibit varied velocities and migration modes such as
collective migration, expansive growth, single-cell migration and combined collectivesingle migration as a function of the composition and physical characteristics of the 3D
microenvironment.
In 3D matrices of Matrigel, the neurospheres adopted a rounded morphology resembling
expansive growth. Such morphology can be associated with the structural characteristics
of the matrix. Matrigel presents different crosslinking patterns as well as larger pore sizes
than native BM,55,67 and does not confine or resist neurosphere expansion. As a
consequence, cells tend to exhibit characteristics related to proteolysis-independent
migration such as amoeboid morphology for single cells68 or expansive growth,25
consistent with the morphology observed in Matrigel 75% and 100%. Our results also
suggest that reduction of matrix stiffness as in Matrigel 50% generates a semi-3D (or
2.5D) substrate where close contact between the neurospheres and the rigid surface of the
culture plate allows the formation of focal contacts and stable multicellular strands
supporting greater migration distances.
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The drastic change of GSCs morphology to strictly elongated, mesenchymal-like, single
migration in type-I collagen corroborates the relevance of the ECM properties on the
regulation of cancer cell migration. Fibrillar collagen although non present in normal
brain ECM, has been found in glioma tissues, surrounding ECM,15 and as a component of
the GSCs niche,(16) suggesting that glioma cells deposit it to support tumor migration.
While previous studies have explored the migration of glioma cells in collagen matrices
by using established cell lines and commercial collagen,46,47,62 we focused on studying
the invasiveness of GSCs due to their role in tumor migration and regrowth. Additionally,
we generated matrices with oligomer collagen that as recent reports showed, offers a
number of advantages over conventional monomeric collagens, including hierarchical
collagen fibril assembly that recapitulates that observed in vivo, presence of tissuespecific intermolecular crosslinks, short polymerization time, and customization over a
broad range of relevant physicochemical features.61 GSC neurospheres exhibited single
cell detachment and mesenchymal migration in all the types of collagen matrices studied,
consistent with the migration mode presented by other glioma cells lines in 3D-collagen
matrices.47,62 The velocity and distance of migration were modulated by the concentration
of the collagen as was expected due to changes in the fibril density and pore size of the
matrix.54,61 In atelocollagen matrices where no crosslinks are present, increasing
concentration resulted in higher migration due to higher generation of cell-matrix
contacts and proteolysis-independent migration. In covalently cross-linked matrices such
as BD-collagen and oligomer, increasing collagen concentration reduces the pore size and
the available space for cell movement; hence, migration relies on the ability of the cell to
degrade and remodel the extracellular matrix, or to deform its body until reaching an
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appropriate size to move through the pores.69 Similarly, reduction of the collagen
concentration and consequent increase of the pore size can also reduce migration due to
the lack of structural support for the development of cell-matrix contacts and generation
of traction force to propel movement. These differences in migration due collagen matrix
concentration are similar to observations by other authors62 and support the existence of
an optimum collagen concentration range where the fibril density and pore size support
the maximum cell migration.70–72

Hyaluronan enrichment of the ECM and overexpression of CD44 receptors have been
associated with glioma invasion of brain parenchyma.73–75 Interestingly, when increasing
quantities of hyaluronan were incorporated to collagen matrices to resemble glioma
microenvironment, the number of migratory cells and migration distance were reduced.
Also, the cell morphology shifted to a more-rounded appearance. Previous studies of
collagen-hyaluronan 3D matrices43,45,46 have related increasing HA concentrations with
matrix stiffness and subsequent reduction of cell migration with adoption of rounded
morphology. Similarly, in PEG-HA matrices, increased stiffness has derived in changes
of cell morphology.76 Nevertheless, our results showed that incorporation of noncrosslinking hyaluronan decreases matrix stiffness (Table S1) but also induces adoption
of cell-rounded morphology. As other studies of acid-solubilized collagen matrices have
shown, HA incorporation increases interstitial fluid movement resistance without
affecting fibril density.(45) Consistently, Col-HA matrices presented a similar fibril
density upon HA addition, however the interfibrilar associations were disrupted.
Therefore, we suggest that the stiffness reduction is linked to reduction fibrillar branching
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caused by HA during matrix polymerization,66 and the adoption of cell rounded
appearance is mainly due to increased resistance of the interstitial fluid caused by
hyaluronan hydration that opposes an additional barrier for cell deformation and
movement.

It is accepted that GBM presents a rapid infiltration pattern with preference for
myelinated axons and blood vessels.(14) Recently it was shown using in vivo xenograft
models that GBM cells present directional and efficient migration (greater net distance
and velocity) along blood vessels while migration through the parenchyma occurs by
expression of multiple pseudopodia with constant changes in direction.78 Certain GBM
cell lines also presented a chain-like morphology when extending from the tumor to the
blood vessels.79 In line with such findings, our results, obtained using an in vitro
composite matrix, suggest that GSCs detect the asymmetric rigidity gradient presented in
the environment and develop different migration modes according to the mechanical
properties of the structures to invade. Migration across collagen-hyaluronan matrix,
which poses a low-stiffness environment triggers cell detachment and single cell
migration with constant changes of direction; however, when rigid structures (as the
microrods) are presented to the neurospheres, the cells develop collective strand
migration along the directional tracts. Such migration mode by multicellular strands was
present along rods regardless of the percentage of Matrigel coverage on the rod surface.
Hence, we suggest that the rigidity of the topographical clue coupled with the proximity
of the neurosphere to the clue induce durotaxis and formation of strand collective
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migration, and that this type of collective migration is likely to be present not only along
blood vessels but also along myelinated axons.80,81

2.5

Summary

In this study we describe a new composite tunable matrix that resembles important
features of glioma microenvironment as ECM composition, mechanical properties and
preexisting structural cues. This model can be used to dissect and increase our
mechanistic understanding of the migratory behavior of GSCs in 3D environments.
Furthermore, we analyzed multiple matrices of varied mechanical properties using
Matrigel and diverse types of fibrillar collagen, to assess how the migratory
characteristics of GSCs are affected by the physical properties of the matrix. Our results
indicate that GSC neurospheres are able to exhibit multiple velocities and migration
modes such as collective migration (expansive growth and strand)82 and single cell
migration (mesenchymal) as a function of the mechanical and compositional properties of
the matrices. In a composite collagen-hyaluronan matrix, the migration of GSCs was
reduced by the presence of hyaluronan; nonetheless, cells adopted a productive and fast
migration as a collective strand by using the preexisting topographical cues presented as
migratory paths. Taken together the results suggest that GSCs migration is not limited to
a unique migration mode as is usually observed in in vitro studies, but are able to exhibit
concomitantly multiple migration modes (collective and single) as a response to the
heterogeneity of the environment. The recreation of additional characteristics of cancer
environments such multiple cell co-culture and functional vascular networks in
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controllable 3D-models is a powerful tool to study cancer development and progression.
Additional efforts in this area will contribute to the elucidation of fundamental
mechanisms such as how cell sensing of the microenvironment composition and
mechanical characteristics induces the adoption of different migration mechanisms.
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CHAPTER 3. INFLUENCE OF THE EXTRACELLULAR MATRIX AND STROMAL
CELLS ON GLIOBLASTOMA DRUG RESPONSE

3.1

Introduction

Recognition of the tumor microenvironment as a biological regulator of GBM
progression is critical not only to elucidate the biological mechanisms involved in tumor
development and progression but also in the early stages of the development of drug
treatments that effectively target the cancer cells and their supportive niche. Presence of
the tumor microenvironment has been correlated with poor response of cancer cells to
chemo- and radiotherapy as well as to inhibition of immune surveillance.51,83,84 An
appropriate example of the importance of the understanding the dynamic relationship
tumor-microenvironment during drug development has been the development of anti
cancer drugs such as Bevacizumab that target the interaction with tumormicroenvironment. Bevacizumab, an antibody that inhibits the vascular endothelial
growth factor-A (VEGF-A) was approved for GBM treatment to directly inhibiting tumor
angiogenesis.85 Despite the overall dismal improvement that Bevacizumab has have on
GBM patients,86 recognition of the synergistic relationship tumor-microenvironment as a
potential drug target has been a fundamental step in the development of more effective
and specific treatment approaches.
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Given the importance of tumor microenvironment during GBM drug response, a close
representation of its multiple components during early stages of drug development is
fundamental for the development of translational therapies. The use of in vitro platforms
that represent more closely the in vivo settings of the tumor microenvironment has
multiple advantages such as presence of cell-ECM interactions and existence of nutrient
and oxygen gradients.83,87 However the majority of these approaches are only focused on
the recapitulation of the 3-dimensionality of the tumor and presence of ECM and very
few have also considered the effect of stromal cells as components of the tumor
microenvironment.
3D scaffold-based co-culture models are powerful tools to represent the tumor
microenvironment since can incorporate the ECM, stromal and tumor cells and allow
controlled analysis of the role of intercellular signaling on tumor behavior. Despite the
great advantages that these models offer for initial drug screening of potential GBM
treatments, a comprehensive 3D model of GBM microenvironment that accounts for
ECM and tumor cell heterogeneity has not been yet developed. In this work we use a 3D
in vitro tissue model that recapitulates the physical characteristics of GBM ECM with
incorporated stromal cells as astrocytes and endothelial colony forming cells (ECFCs) to
determine the role of both, extracellular matrix and stromal cells presence on the viability
of GBM after drug treatment. To achieve a more comprehensive conclusion on the effect
of microenvironment on GBM survival, we used multiple patient derived GBM cell lines,
including stem-like and non-stem GBM cells. Furthermore, different drug treatments
were tested such as temozolomide, Nutlin-3a and the STAT3 inhibitor SH-4-54.
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Temozolomide is the standard chemotherapeutic agent for GBM treatment and acts by
damaging (through methylation) the DNA and inducing cell death. Nutlin-3a acts as a
MDM2 inhibitor, a negative regulator of p53 tumor suppressor and has shown very
promising results for treatment of multiple cancers types, especially in combination with
other treatments.88,89 Lastly, we used a newly developed small molecule inhibitor of
signal transduction and activator of activation STAT3 (SH-4-54), this drug acts by
inhibiting the phosphorylation of STAT3 required for activation of genes involved in
cancer associated processes as metastasis, proliferation and survival and has been proved
to effectively reduce survival of brain tumor initiating cells (also called tumor stem-like
cells).90
3.2

Experimental Methods

3.2.1 Cell culture in liquid substrates
GBM human–derived cell lines GBM10 and GBM43 were originally obtained from Dr.
Jann Sarkaria (Mayo Clinic, Rochester, MN) and have been described elsewhere.91
MHBT32 is a low passage primary patient line kindly donated by the Dr. Karen Pollok
and Dr. Aaron Cohen at Indiana University and the Methodist Hospital of Indianapolis.
All cell lines were maintained in high-glucose DMEM (Life Technologies, Carlsbad, CA)
supplemented with 10% FBS. Cell line U87MG was maintained in IMDM (Life
Technologies, Carlsbad, CA) supplemented with 10% FBS. GBM human cell line
GBAM1 (CD133+ >98% from passages 22-25) provided by Dr. Phillip Tofilon and the
Moffitt Cancer Center was maintained in DMEM/F12 supplemented with B27 without
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vitamin A (Life Technologies, Carlsbad, CA) and with growth factors EGF, bFGF (50
ng/ml each, Peprotech, Rocky hill, NJ). Human primary astrocytes from ScienCell
(Carlsbad, CA) were maintained according to vendor specifications. Endothelial
umbilical cord blood ECFCs from EndGenitor Technologies (Indianapolis, IN) were
cultured in collagen type-I coated T-75 flasks in EGM-2 medium (Lonza, Walkersville,
MD). All cell lines were cultured at 37°C in an atmosphere of 5% CO2, fed with complete
media every other day and passaged at 70-80% confluence.

Table 3.1 Properties of human-derived GBM cell lines
Cell line

EGFR
Amplification
GBAM1(CD133+)
GBM10
No
GBM43
No
MHBT32
3.2.2

PTEN
status
wt
wt
-

p53 status

p16 deletion

wt
170 Phe>Cys
-

Yes
Yes
-

Cell culture in the 3D brain-like matrix

3D matrices of collagen-hyaluronan were generated using pig skin oligomer collagen
(GeniPhys, Zionsville, IN) at concentration 2 mg/ml as described by Whittington (2013).
Sodium hyaluronate (MW 351-600) KDa (Lifecore Biomedical, Chaska, MN) was
dissolved in 10X PBS during collagen neutralization to attain a final concentration of 10
mg/ml of hyaluronan. GBM cells were suspended at the desired density in the 3D matrix
prior polymerization at 37°C for 30 minutes. Complete media was added to the top of the
matrix, and cells were cultured at 37°C in an atmosphere of 5% CO2.
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3.2.3

Drug treatments

GBM cells were cultured for 24 h (in liquid medium or within the 3D Col-HA matrix) in
a 96-well plate at 5000 cells/well with 100 µl of complete media prior addition of onetime dosage of the drug treatments. Co-culture of GBM with with stromal cells was done
at a ratio 1:1 or 1:1:1. The drugs Nutlin-3a, anti-STAT3 inhibitor SH-4-54 and
Temozolomide (TMZ) (Sigma-Aldrich, St. Louis, MO) were dissolved in DMSO and
added to a total of 200 µl of medium per well. Controls were treated with DMSO.
Combination drug treatments of SH-4-54 at fixed concentration of 5 µM with varied
concentration of Nutlin-3a (0 - 50 µM) were performed in liquid and 3D culture for
GBAM1 and GBM10. Dual combination of Nutlin-3a (25 µM) and SH-4-54 (5 µM) or
triple combination of Nutlin-3a (25 µM)+ SH-4-54 (5 µM)+TMZ (1050 or 750 µM) were
tested both in liquid and 3D culture in GBAM1 and GBM10 cell lines.

3.2.4

Assessment of cell viability

Viability of GBM cells cultured as 2D monolayer or in 3D Col-HA matrix was assessed
72h or 120h after drug treatment using Alamar blue assay (ThermoFisher Scientific,
Waltham, MA). Alamar blue solution was added to each well to reach 10%v/v; cells were
incubated with the reagent for 3h at 37°C and fluorescence was measured (560 nm
excitation - 590 nm emission). Readings were normalized to DMSO control to calculate
viability percentages.
For assays involving co-culture of GBM with astrocytes and ECFCs the GBM cells were
marked with CellTracker™ Green CMFDA dye (ThermoFisher Scientific, Waltham, MA)
prior 3D culture and drug treatment. Viability was assessed using confocal microscopy
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by treating the samples for 10 min with viability dye eFluor 660 (eBiosciences) 72h after
drug treatment. Total GBM cells were detected by Celltracker green and dead GBM cells
by colocalization of both dyes using ImageJ software.

3.2.5

Statistical analysis

All measurements are expressed as mean SD unless otherwise stated. Comparisons
between treatments were made using two samples t-test or one-way analysis of variance
(ANOVA) with Tukey-Kramer mean comparison. Analysis of effect of drug treatment
and presence of other cells on GBM migration was made using two-way analysis of
variance with Tukey-Kramer mean comparison. Statistical significance was evaluated at
α = 0.05.

3.3

3.3.1

Results

Effect of temozolomide (TMZ) treatment on GBM cell viability in 2D liquid
culture

GBM cell lines were treated with varied concentration of temozolomide (TMZ) as a onetime dosage, and cell viability was evaluated 5 days after treatment using Alamar blue
assay. The concentration range of treatment was chosen based on previous studies by
collaborators for IC50 determination (data not shown). We observed that all the cell lines
exhibited a weak response to low TMZ concentrations (Fig 3.1). TMZ IC50 for cell lines
GBAM1, GBM10 and GBM43 was reached at 753, 1383 and 800 µM respectively; these
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values were much higher than previously determined by our collaborators using a
methylene blue proliferation assay (Table 3.2). TMZ IC50 for MHBT32 was reported at
5.8 µM (Table 3.2), however in our hands, this cell line showed low response to treatment
and constant viability of 80% after TMZ treatment from 25 to 200 µM.
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Figure 3.1 Patient derived GBM cell lines exhibit weak response to TMZ treatment in 2D
liquid culture. MHBT32 cell line was resistant to increasing concentrations of TMZ. Data
presented as Mean ± SD (n=>3)

Table 3.2 Comparison of GBM TMZ IC50 in 2D liquid culture. Relative IC50 calculated
are higher than IC50 previously determined by collaborators.

GBAM1
GBM10
GBM43
MHBT32

TMZ
Reported
(2D)
Unknown
923
263
5.8

TMZ Liquid
(2D)

Nutlin-3a
(2D)

735
1383
800
> 200

110
40
26
17

55
3.3.2

Effect of MDM2 and STAT3 inhibitors on GBM cell viability

Given the poor response to temozolomide exhibited by all GBM cell lines studied, we
tested the effect on viability of the MDM2 inhibitor Nutlin-3a alone and in combination
with SH-4-54, a newly synthesized STAT3 inhibitor. Cell viability was evaluated 72h
after drug treatment with concentrations of Nutlin-3a ranging from 5 to 50 µM as single
treatment or combined with a 5 µM of SH-4-54. Treatment with Nutlin-3a decreased
viability in all cell lines (Fig 3.2). Concentrations of Nutlin-3a as low as 5 µM reduced
viability of GBAM1, GBM10 and U87MG to 82%, 75% and 35% respectively. Yet,
increasing Nutlin-3a concentration to 25 µM did not affect viability when compared to 5
µM. Further increase in Nutlin-3a concentration to 50 µM caused a drastic decrease in
GBM viability, especially in GBM43 and U87MG than presented only 20% viability
after treatment. Stem-like GBAM1 presented less sensitivity to Nutlin-3a than the other
cell lines reaching 65% viability at maximum concentration studied (50 µM). Treatment
with SH-4-54 reduced viability of stem-like GBAM1 when combined with 5 and 50 µM
of Nutlin-3a, however combination treatment had no effect on GBM10, GBM43 or
U87MG viability compared to single Nutlin-3a treatment.
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Figure 3.2 Nutlin-3a treatment decreases the viability of all GBM cell lines studied.
Combination of Nutlin-3a with SH-4-54 further decreases viability in stem-like GBM cell
line GBAM1 but does not potentiate the effect of Nutlin-3a in non-stem GBM cells. *
Represents statistical difference at α=0.05.

3.3.3

Dimensionality influences GBM response to drug treatment

Since the cell lines GBM10 and stem-like GBAM1 presented similar responses to TMZ
and Nutlin-3a but had very different responses to anti-STAT3 treatment, we evaluated the
drug response of cells cultured both, in standard 2D liquid monolayer and in a brain-like
3D model of collagen-hyaluronan. GBM viability after drug treatment tends to be higher
for cells cultured in the 3D model compared to 2D liquid, although in certain cases, for
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instance when the drug effect is very low (SH-4-54 on GBM10) the difference in survival
between 3D and 2D culture is not significant. Interestingly, GBM10 treatment with
Nutlin-3a showed a very different tendency compared to other drugs and cell lines, in this
particular case, viability during 3D culture was lower than in 2D liquid. In general, in
contrast to 2D liquid culture, viability in 3D culture after treatment was greater than 75%
despite the drug or concentration used, which likely suggests that dimensionality and
presence of the extracellular matrix plays a role on GBM survival after chemotherapeutic
treatment.
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3.3.4

3D co-culture with astrocytes increases viability of GBAM1 after TMZ treatment

Stromal cells present in the tumor microenvironment influence tumor progression. In the
case of brain, astrocytes are the main non-neural cell type and comprise nearly 50% of
total brain volume. To determine the influence of stromal cells in GBM drug response,
we incorporated astrocytes along with GBM cells into the 3D model of collagenhyaluronan to evaluate GBM survival after treatment with temozolomide. Incorporation
of astrocytes significantly increased viability of the stem-like cell line GBAM1 after
TMZ treatment compared to GBM 3D culture without astrocytes (Fig 3.4). In contrast,
there was only a slight increase in GBM10 viability in presence of astrocytes. Presence of
astrocytes in the 3D model increased viability of the stem-like cell line GBAM1 from 60%
to 120% and from 59% to 72% in GBM10 after TMZ treatment when compared to 2D
liquid culture, showing that combined factors such as presence of the ECM and brain
stromal cells can act synergistically to decrease GBM sensitivity to drug treatment when
compared to standard 2D liquid culture.
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Figure 3.4 Astrocyte co-culture with GBM in 3D culture decreases the cytotoxic effect of
temozolomide in GBAM1 compared to only-GBM 3D culture. * Represents statistical
difference at α=0.05.

3.3.5

3D co-culture with ECFC and astrocytes increases viability of GBM after drug
treatments

A hallmark of GBM is the ability to induce angiogenesis to support tumor growth.
Vascular proliferation is a defining histological feature separating GBM from lower
grades of astrocytoma. To address the importance of endothelial cells in the GBM
microenvironment and therefore tumor drug response, we incorporated endothelial
colony forming cells (ECFCs), able to form vascular networks, with astrocytes and GBM
cells into the 3D model of GBM ECM. The multicellular 3D model was then treated
with the STAT3 inhibitor SH-4-54, combination of Nutlin-3a (25 µM) – SH-4-54 (5 µM)
and triple combination of Nutlin-3a (25 µM) – SH-4-54 (5 µM) - TMZ (750 µM for
GBAM1 and 2100 µM for GBM10) to determine the effect of normal brain cells on
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GBM survival. Presence of astrocytes and ECFCs increased GBAM1 survival to nearly
100% survival after treatment with SH-4-54 compared with 38% in 2D liquid culture, and
80% in 3D culture. GBAM1 viability after dual or triple drug combination was higher in
co-culture with ECFCs and astrocytes compared to liquid culture but not significantly
different than in 3D culture without stromal cells. Co-culture of astrocytes and ECFCs in
the 3D GBM10 cultures increased survival following triple treatment from 35% in liquid
culture and 25% in 3D culture without stromal cells to 75% in 3D co-culture.

Interestingly, GBM cells cultured in the 3D model with ECFCs and astrocytes exhibited
an overall survival higher than 70% despite the drug combination that was applied. The
effect of ECFCs and astrocytes on increasing GBM survival was especially evident after
drug treatments that were very effective in decreasing survival in 2D culture such antiSTAT3 drug SH-4-54 for GBAM1 and triple combination of SH-4-54 - Nutlin-3a - TMZ
for GBM10.
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Figure 3.5 Presence of stromal cells in the 3D extracellular matrix drastically reduces the
cytotoxic effect SH-4-54 STAT3 inhibitor on GBAM1 and the effect of triple drug
combination of GBM10. * Represents statistical difference at α=0.05.

3.4

Discussion

Despite the widely recognized importance of the microenvironment as modulator of
tumor behavior, current models for drug screening do not recapitulate the essential
components of the tumor microenvironment like the presence of extracellular matrix and
stromal cells. Previous studies have shown that cancer cells cultured in 3D environments
can present either higher or lower sensitive to chemotherapeutic agents compared to cells
cultured in standard 2D liquid culture.92–97 Although assessment of drug response varies
widely depending on factors such as cancer cell line studied, 3D-culture approach, drug
evaluated or presence of non-tumor cells, it has become clear that many characteristics of
the microenvironment play a role in how cancer cells respond to treatment. In this study
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we evaluated the effect of the extracellular matrix and presence of brain stromal cells on
survival of GBM after treatment with chemotherapeutic agents by using a developed 3D
model that recapitulates the characteristics of the brain extracellular matrix and the
presence of brain stromal cells. We observed that presence of a 3D extracellular matrix as
well as astrocytes and ECFCs increases the survival of GBM stem-like cells after drug
treatments compared to standard 2D liquid culture. Similarly, dimensionality and stromal
cells affected viability of non-stem cells after treatment, however the drug effect was
diminished or dependent on the drug tested when compared with GBM stem-like cells. Is
important to note that GBM10 in 2D and 3D-matrix culture was relatively resistant to all
treatments except to triple treatment, hence the effect of extracellular matrix and stromal
cell on GBM10 viability was only well appreciated following triple drug treatment.

Evaluation of survival after drug treatment performed in 2D liquid culture showed that
the GBM cell lines used in this study present low sensitivity to TMZ (IC50 values higher
than 700 µM) as well as varied sensitivity to the MDM2 inhibitor Nutlin-3a and STAT3
inhibitor SH-4-54. Nutlin-3a treatment visibly reduced the viability of non-stem GBM
cells lines GBM10, GBM43 and U87MG but had a lesser effect on viability on the stemlike cell line GBAM1. Sensitivity of the non-stem cell lines GBM10, GBM43 and
U87MG to Nutlin-3a can be linked to p16 deletion in GBM10 and GBM4391 and in
U87MG. Given the decreased functionality of p16, that functions as an MDM2 negative
regulator, we expected higher than normal MDM2 activity in these lines. Disruption of
the MDM2-p53 interaction by Nutlin-3a and consequent reduction of p53 degradation
will lead to decreased viability especially in cells with high activity of MDM2 as the non-
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stem GBM lines studied. Effectively, Nutlin-3a reduced the viability of non-stem cell
lines presenting mutations on p16 compared to the stem-like cell line GBAM1. Previous
studies have recognized Nutlin-3a as an inducer of cell cycle arrest and apoptosis in wtp53 GBM cell lines.98 Interestingly, our results show that p53 mutants such as GBM43
respond to Nutlin3a treatment in a similar way than wt-p53 cell lines GBM10 and
U87MG. When Nutlin-3a was combined with the anti-STAT3 inhibitor SH-4-54 as an
attempt to decrease viability, only stem-like cells showed reduction in viability compared
to only Nutlin-3a treatments. Our results are in concordance with previous studies that
shown that inhibition of STAT3 function is detrimental for the proliferation and survival
of stem-like brain cancer cells90,99. Studies by Rahaman (2002)100 demonstrated that
inhibition of constitutive expression of STAT3 is lethal for GBM cells. In our studies we
did not observe such lethality, likely due to the fact that SH-4-54 inhibits phosphorylation
and dimerization of STAT3 but does not deplete constitutively expressed STAT3.

Evaluation of the role of dimensionality on GBM viability was performed in GBM10 and
GBAM1 by comparing viability after drug treatment in liquid culture and in the 3D
model. Presence of ECM influenced viability of the stem-like line GBAM1 regardless of
the drug treatment applied. In all cases presence of the 3D ECM reduced the
effectiveness of the drug and increased GBAM1 cell viability. Previous assessment of
the effect of dimensionality on stem-like GBM cells was done on collagen surfaces as
semi 3D-culture platforms. Similar to our results GBM stem-like cells treated with other
drugs like multikinase inhibitors exhibited increased viability in semi 3D platforms
compared to liquid culture.97
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The effect of the ECM on GBM10 viability differed depending on the treatment applied.
Presence of the 3D ECM reduced the effectiveness of TMZ but increased the effect of
Nutlin-3a. Viability after treatment with the inhibitor SH-4-54 was very similar in 2D and
in 3D, likely due to poor effectiveness of the compound to decrease GBM10 viability or
due to lack of STAT3 activity. Drug response has been previously evaluated in 3D
platforms and compared to 2D liquid response in various cancer cell lines with mixed
outcomes regarding the effect of the ECM on increasing or decreasing sensitivity of cells
to treatment. For instance, chemotherapeutic agents such as doxorubicin, paclitaxel and
tamoxifen were less effective in reducing viability of breast cancer cells in 3D matrices
compared to liquid culture.96,101 In contrast, other studies suggest that pancreatic and
breast cancer cells cultured in 3D matrix presented increased sensitivity to drug treatment
compared to liquid culture.94,95

Different to the effect of ECM, the role of stromal cells on cancer drug response has been
less explored. Previous attempts to assess the effect of stromal cells on cancer viability
after drug treatment were performed in 2D liquid culture or using cancer cell spheroids.
In both studies it was observed that the presence of stromal cells such as astrocytes and
fibroblasts reduced effectiveness of drug treatments in GBM and breast cancer
respectively.102,103 Still, to the best of our knowledge our 3D model for multiple coculture of stromal and GBM cells is the first attempt to recreate an in vitro brain tumor
microenvironment that combines dimensionality, similar GBM ECM and stromal cells
for testing the effectiveness of drug treatment on GBM. Similar to the results obtained by
Chen (2015),103 which demonstrated that GBM and astrocytes co-culture at a ratio 2:1
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decreased GBM apoptosis after TMZ or vincristine treatment, we observed that a
protective effect of astrocytes. Presence of astrocytes at a ratio 1:1 to GBM cells
decreased sensitivity of GBAM1 to TMZ compared to both liquid culture and 3D culture
without stromal cells. In contrast, presence of astrocytes decreased sensitivity of GBM10
compared to liquid culture and not to the 3D culture without astrocytes.
Dual presence of astrocytes and ECFCs reduced the effect of drug treatments that were
very effective in liquid culture in both non-stem and stem-like GBM cell lines.
Interestingly, we observed that presence of stromal cells in the 3D microenvironment had
a greater effect on protecting the stem-like cell line GBAM1 against chemo-agents
compared to the non-stem cell line GBM10. The greater effect of the microenvironment
decreasing the sensitivity of the GBM stem-like cells to drug treatments suggest that for
cancer stem-like cells as for normal cell progenitors the microenvironment is a complex
and dynamic entity that regulates, supports and protects stem cell function.

3.5

Summary

In this study we described the effect of different components of the tumor
microenvironment such as dimensionality and presence of stromal cells on the sensitivity
of GBM cells to various chemotherapeutics agents. To this end we generated a 3D model
that represents the physical, compositional characteristics of GBM ECM as well as the
presence of stromal cells astrocytes and vasculature-forming cells. Presence of a 3D
matrix with similar composition to GBM ECM decreased the cytotoxic effect of TMZ,
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Nutlin-3a and STAT3 inhibitor SH-4-54 on the stem-like line GBAM1 compared to
standard 2D liquid culture; however had a varied effect in the non-stem line GBM10.
Incorporation of astrocytes within the 3D GBM ECM model further reduced the effect of
TMZ on GBAM1 compared to liquid culture and GBM 3D culture without stromal cells.
Astrocyte presence reduced sensitivity of the non-stem cell line GBM10 compared to
liquid culture but had little effect compared to 3D culture without stromal cells,
suggesting a possible greater protective effect of astrocytes on GBM stem-like cells.
Combined presence of ECFCs and astrocytes into the 3D model decreased the toxicity of
drug treatments on GBAM1 compared to liquid culture, and reduced the toxicity of
STAT3 inhibition compared to 3D culture without stromal cells.
Presence of stromal cells had a lesser effect on GBM10 viability. Is important to note that
GBM10 was isolated form a recurrent GBM patient and presented overall poor response
to drug treatment. Therefore, the effect of the stromal cells on viability was only evident
after aggressive treatment with triple combination of TMZ - Nutlin-3a - SH-4-54.
The recreation of an in vitro model of the tumor microenvironment offers a unique tool to
study how different factors of the environment contribute to GBM response to chemoagents in order to generate therapies potentially translational to in vivo settings.
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CHAPTER 4. DIMENSIONALITY AND PRESENCE OF STROMAL CELLS
INFLUENCE GLIOBLASTOMA MIGRATION

4.1

Introduction

Glioblastoma (GBM) is characterized by rapid infiltration across brain parenchyma. Prior
to tumor surgical resection, cells from the primary mass leave the tumor and invade
healthy brain tissue to form new satellite tumors that ultimately lead to patient relapse.14
Synergistic relationships between tumor cells and the local microenvironment have been
recognized as fundamental modulators of GBM migration and colonization strategies.104–
106

During GBM development, intercellular signaling between tumor cells and normal

tissue constitutes one of the first steps towards the formation of a supportive
microenvironment. Recruitment of supportive stromal cells such as vasculature forming
cells during angiogenesis, and suppression of microglia and T-cells normal functions are
essential for the maintenance of the tumor as a functional, self-regulating entity. 107
Interactions of the tumor with its microenvironment and paracrine signaling with the
supportive stroma promote GBM migration and are associated with the presence of
similar migration patterns exhibited by the neural progenitors during early stages of the
central nervous system (CNS) development.13 Such specific interactions are also linked to
the unique rapid and productive infiltration of GBM into healthy tissue when compared
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to other types of cancer. Further evidence of the importance of tumor-microenvironment
interaction is the possible correlation between tumor location and patient survival.
Patients with GBM located in the deep grey matter, which is formed mainly by the
neurons cell body, present longer survival that patients with GBM located in the brain
lobes, formed mainly by the axonal section of the neurons and astrocytes.108
Brain tissue is comprised by multiple types of cells; among the most prevalent
populations are astrocytes, microglia, neurons and the cells comprising the vascular
network (endothelial cells and pericytes). Astrocytes are the main glial components of
brain stroma.38 Previously, astrocytes were considered only as supporters of neural
function and component of the brain blood barrier, only until recently their full function
in maintenance of brain homeostasis has begun to be comprehended. Astrocytes undergo
astrogliosis in presence of GBM cells,109 in a response that recapitulates their behavior
after CNS injury. Reactive astrocytes increase secretion of cytokines that facilitate cell
growth and migration as a response mechanism to control brain damage.39 It has been
hypothesized that GBM take advantage of astrogliosis signaling to facilitate
invasion.38,40,109,110 Among the most important signals associated with astrogliosis and
involved in tumorigenesis is the up-regulation of matrix metalloproteinases (MMP)
expression. MMPs are a family of proteinases able to remodel the microenvironment
through degradation of multiple component of the extracellular matrix.111 Besides being
important drivers of invasion (migration, extravasation and intravasation), MMPs are also
potent regulators of angiogenesis, and inflammation, all processes deregulated in
cancer.111
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MMP activity is regulated through many strategies, by repression of expression, presence
of inhibitors, or secretion of an inactive isoform that will be activated by signaling cues
of the microenvironment when required.111 The delicate balance of inhibiting MMPs is
fundamental to avoid undesired degradation of tissue. However, during tumorigenesis the
MMP activity is up-regulated facilitating the remodeling of the tumor microenvironment
and the migration of cancer cells. Greater presence of MMPs in the GBM
microenvironment has been associated to two factors, increased MMPs secretion by
tumor cells or activation of present MMPs induced by paracrine signaling with the
microenvironment, specifically with astrocytes.
Similar to astrocytes, recruitment of endothelial cells by GBM is a driving factor that
contributes to tumor migration. Cooperative interaction between endothelial cells and
GBM induces expression of pro-angiogenic signals, atypical proliferation of endothelial
cells and tumor neovascularization.37 Neovascularization is a hallmark of GBM and of
the most important processes that lead to the rapid progression and invasion of the tumor.
Due to the rapid proliferation of the cancer cells and destabilization of the vasculature,
the tumor presents hypoxic regions that express hypoxia-inducible factor (HIF) α and β.
As a response to hypoxia the tumor cells up-regulate the expression of vascular
endothelial growth factor (VEGF) and attracts endothelial cells to initiate the formation
of new vasculature. 85 New vascular networks can acts as migration routes for invasion of
the tumor into healthy parenchyma.
Despite the well-recognized reciprocal interaction between the tumor and its
microenvironment, many GBM studies are performed in formats that fail to recapitulate
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the main characteristics of the tumor microenvironment, namely, presence of
extracellular matrix and stromal cells. Here, we use a previously developed 3D in vitro
model that recapitulates the compositional and mechanical features of GBM ECM with
incorporated astrocytes and endothelial cells to elucidate the role of different components
of tumor microenvironment on the migration of GBM.
4.2

4.2.1

Experimental Methods

Standard liquid cell culture

GBM human–derived cell lines GBM10, GBM43 and MHBT32 were maintained in highglucose DMEM (Life Technologies, Carlsbad, CA) supplemented with 10% FBS. GBM
human cell line GBAM1 (CD133+ >98%) was maintained in DMEM/F12 supplemented
with B27 without vitamin A (Life Technologies, Carlsbad, CA) and with growth factors
EGF, bFGF (50 ng/ml each, Peprotech, Rocky hill, NJ). Human primary astrocytes from
ScienCell (Carlsbad, CA) were maintained according to vendor specifications.
Endothelial umbilical cord blood ECFCs from EndGenitor Technologies (Indianapolis,
IN) were maintained in collagen type-I coated plates with EGM-2 medium (Lonza,
Walkersville, MD) as described by Whittington (2013). All cell lines were cultured at
37°C in an atmosphere of 5% CO2, fed with complete media every other day and
passaged at 70-80% confluence. To obtained astrocyte conditioned medium, astrocytes
were seeded at an initial density of 5000 cell/cm2 and cultured according to vendor
specifications for 5 days, the media was collected centrifuged at 1000rpm for 5 min to
eliminate possible present cells.
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4.2.2

3D Cell culture

3D matrices of collagen-hyaluronan were generated using pig skin oligomer collagen
(GeniPhys, Zionsville, IN) at concentration of 2 mg/ml and sodium hyaluronate (MW
351-600) KDa (Lifecore Biomedical, Chaska, MN) was incorporated at 10 mg/ml as
described previously in Chapter 2. Cells were suspended at the desired concentration in
the 3D matrix prior polymerization at 37°C for 30 minutes. Complete media was added to
the top of the matrix, and cells were cultured at 37°C in an atmosphere of 5% CO2.

4.2.3 Migration on 2D surfaces
Cells were tested for viability, stained with CellTracker™ Green CMFDA dye (Life
Technologies, Carlsbad, CA) for visualization and plated on glass-bottom well plates at a
density of 15000 cell/cm2 and fed with appropriate media; plates used for GBAM1 cells
were coated with 1.5 µg/ml of Poly-L-lysine in water. For migration assays involving coculture with astrocytes or with astrocytes and ECFCs, astrocytes and ECFCs were
initially plated at 15000 cell/cm2 density and cultured 24h before the addition of GBM
cells to allow attachment to the plate surface. After GBM addition to the co-culture, cells
were fed with media containing equal volumes of complete GBM, astrocytes and ECFC
media and incubated during 4h for attachment of GBM cells and placed in an on-stage
incubator chamber to perform time-lapse confocal microscopy every hour during 15h.
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4.2.4

Migration in 3D brain-like matrix

GBM cells were stained with CellTracker™ Green CMFDA dye (Life Technologies,
Carlsbad, CA) and embedded at a density of 1*106 cells/ml within the collagenhyaluronan matrix before polymerization. For assays involving astrocytes and/or ECFCs,
all the cells were embedded at the same time in the matrix prior polymerization and at the
same density (1*106 cells/ml each population). Volumes of 30 µl of matrix per well were
platted in a µ-slide angiogenesis chamber (Ibidi, Germany). After matrix polymerization,
30 µl of media were added per well, co-cultured cells were fed with media containing
equal volumes of GBM, astrocytes and ECFC media and maintained in incubation at
37°C in an atmosphere of 5% CO2 for 24 h. Afterwards, cell were placed in an on-stage
incubator to perform time-lapse confocal microscopy every 90 min during 15h.

4.2.5

Time-lapse confocal imaging and migration analysis

Cell migration was monitored by time-lapse microscopy using an Olympus FV1000
confocal microscope equipped with 488 nm argon laser (Figure 4.1). Optimal growth cell
conditions were maintained using on-stage incubator chamber at 37°C in an atmosphere
of 5% CO2. Z-stacks of 200 µm were acquired using 12-15 µM steps; initial and final z
positions were chosen to be at least 50 µm separated of the surface or the plate interface.
Different areas (4 to 9 areas) were acquired per sample (each individual area of 0.0187
mm2) to cover at least 60% of the total area of the well. Image stacks were projected as
XY images for migration analysis. Trackmate plugin from FIJI was used to analyze the
time-lapse images using LoG (Laplacian of Gaussian) detector, assuming a blob diameter
of 10 pixels (all images were 512 pixels, 2.67 µM per pixel) and threshold of 1 pixel,
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without sub-pixel localization. LAP tracker option was chosen allowing frame to frame
linking and closing of 15 pixels in 3D migration experiments and 25 pixels in 2D
migration experiments. Data was filtered to only account for cells visible during the total
time of the experiment. Raw data from Trackmate was analyzed using the Chemotaxis
tool plugin for ImageJ (Ibidi, Germany) to obtain accumulated distance, net distance and
directionality (ratio of net to accumulated migration distance). Accumulated distance
represents all the distance travelled by the cell while net distance only represents the
distance between the initial and final position of the cell. Migration velocity was
calculated by dividing accumulated distance by total time of migration. Directionality as
evaluated here makes reference to intrinsic directionality and represents the degree of
persistence of movement of a cell in the absence of a directional stimulus.
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Figure 4.1 Experimental setup to analysis GBM migration in co-culture with stromal
cells. A. Cell populations are expanded in liquid culture, recovered and labeled with
different fluorophores for movement tracking. B. Individual cells are tracked over time
every 1.5h by confocal microscopy. C. Images generated are analyzed to obtain the
position of every cell on time and calculate the displacement trajectories. D. Initial and
final position of the cells are used to evaluate the directionality of movement.
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4.2.6

Modified 3D co-culture culture method for protein extraction

GBM cells were embedded in collagen-hyaluronan matrices at a density of 3.5*105 cells
in 200 µl of matrix and platted in 48 multi-well plates for polymerization. To achieve 3D
co-culture of astrocytes and GBM that allowed protein extraction of the different
populations, the polymerized matrix containing the GBM cells was recovered and placed
in the center of a well in a 24 multi-well plate. Subsequently 200 µl of collagen matrix
with 3.5*105 astrocytes were pipetted to the surroundings to form a concentric ring with
the astrocytes layer in the outside and the GBM layer inside. The matrices were incubated
during 30 min at 37°C to allow complete polymerization. Media containing equal
amounts of astrocyte and GBM media were added to the culture. Cells were maintained
at 37°C in an atmosphere of 5% CO2 for 72 h. For protein extraction the concentric ring
was separated to obtain the layers containing each of the cell populations.

4.2.7

Western Blot analysis

Cells in 3D culture were washed with ice-cold PBS and incubated with RIPA buffer
supplemented with 1X Halt™ protease and phosphatase inhibitor cocktail (ThermoFisher
Scientific, Waltham, MA) at 4°C for 3 h with constant agitation followed by
centrifugation at 12000 rpm during 20 min to recover the supernatant. Total protein
concentration was quantified by Pierce BCA protein assay (ThermoFisher Scientific,
Waltham, MA). Equal amounts of protein samples were denaturalized and loaded in 4-20%
polyacrylamide gels (Biorad, Hercules, CA). Samples were transfer to PVDF membranes
(ThermoFisher Scientific, Waltham, MA). Membranes were blocked with Odyssey
blocking solution TBS (Licor, Cambridge, UK) at room temperature for 1 h and
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incubated with primary antibody diluted in blocking solution during 12 h at 4°C.
Afterwards, membranes were washed three times for 3 min each with TBS-T buffer
(0.075% Tween-20) and incubated with secondary antibody 1 h at room temperature.
Prior to visualization, membranes were washed 3 times 3 min each with TBS-T buffer.
Primary antibodies used were β-actin (dilution 1:1000), MMP-9 (1:1000) from Cell
Signaling (Danvers, MA), and MMP-2 (1:1000), MMP-14 (1:1000) from Abcam
(Cambridge, UK). Secondary antibodies IRDye800CW anti-rabbit and IRDye680RD
anti-mouse (Licor, Cambridge, UK) were used at a dilution 1:2000. Visualization was
performed in Odyssey Clx System (Licor, Cambridge, UK). Quantification of western
blot band intensity was performed in ImageJ.

4.2.8

Statistical analysis

All measurements are expressed as mean ± SE unless otherwise stated. Statistical
analysis was performed in Origin. Comparisons between treatments were made using two
samples t-test or one-way analysis of variance (ANOVA) with Tukey-Kramer mean
comparison. Statistical significance was evaluated at α = 0.05.
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4.3

Results

4.3.1 GBM migration in 3D brain-like matrix is slower and more directional than in 2D
rigid surfaces

Despite the increasingly recognized influence of the 3D microenvironment on cell
adhesion and migration, cell migration is usually evaluated in 2D rigid or semirigid
platforms by scratch assay or Transwell migration assays. To identify and quantify the
differences of migration in 2D liquid culture and a 3D matrix platforms we compared
distance, velocity and directionality (persistence) of migration of three different GBM
cell lines (GBM10, GBM43 and GBAM1) when cultured on a rigid culture dish (standard
2D liquid culture) and within a 3D matrix of collagen-hyaluronan that recapitulates
composition and mechanical properties of GBM ECM. All GBM cell lines studied
showed greater accumulated migration distance in 2D culture compared to culture in 3D
Col-HA matrix (Fig 4.2). However, comparison among cell lines showed that non-stem
GBM lines GBM43 and GBM10 exhibited higher migration distances on 2D platforms
compared to the stem cell line GBAM1. Interestingly, cell line GBM10 that reached the
greatest migration distance in 2D exhibited very low migration distances when cultured
in the 3D matrix. A similar trend was observed for net migration distances, where 2D
platforms offered a more permissive migration platform compared to the 3D matrix.
Analysis of directionality of migration showed that directionality of GBAM1 and
GBM43 was higher in 3D culture compared to 2D culture, this was to be expected given
the presence of extracellular matrix promotes protrusion stabilization during migration.80

78
A

B

Migration velocity (µm/h)

C

*

*

160
140
120
100

*

80
60
40
20
0

GBAM1

3 D GBM10
GBM10

2 D GBAM1 3D GBAM1 2 D GBM10

*

18

Net migration distance (µm)

160

180

3D GBM43
GBM43

2D GBM43

14

*

100

*

80
60

*

40
20
0

GBAM1

3 D GBM10
GBM10

2 D GBAM1 3D GBAM1 2 D GBM10

*

3D GBM43
GBM43

2D GBM43

*

0.8

12
10

120

1.0

16

*

140

D

Directionality

Accumulated distance (µm)

200

*

8
6
4

0.6
0.4
0.2

2
0.0

0
2 D GBAM1 3D GBAM1 2 D GBM10

GBAM1

3 D GBM10

GBM10

2D GBM43

3D GBM43

GBM43

2D liquid

2 D GBAM1 3D GBAM1 2 D GBM10

GBAM1

3 D GBM10

GBM10

2D GBM43

3D GBM43

GBM43

3D brain-like matrix

Figure 4.2 Migration of GBM in a 3D matrix presents short accumulated and net
migration distance and higher intrinsic directionality. A. Accumulated distance of
migration in 15h. B. Migration distance between initial (0 h) and final migration point (15
h). C. Migration velocity calculated as accumulated distance over total time. D.
Directionality of migration (accumulated/net distance). Data represent n=400-1500
individual cells and is presented as boxes indicating first, second and third quartile and
outliers. * Represents statistical difference at α=0.05.
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4.3.2

Interaction with astrocytes increases GBM migration in 2D culture

Glioblastoma (GBM43)
Astrocytes

200 μm

Figure 4.3 Astrocytes and GBM cells in 2D co-culture have direct physical contacts.
Astrocytes present a more extended morphology that covers almost completely the 2D
surface compared to the GBM cells despite been present at the same density.

As demonstrated, clear differences between migration on 2D surfaces and in 3D matrices
exist. To gain further insight into differences between 2D and the 3D matrices we next
tested the effect of astrocytes on GBM migration. We generated a layer of astrocytes on a
rigid surface and seeded GBM cells on the astrocyte layer. With this experiment we
attempted to corroborate that astrocytes have the same effect on 3D migration of nonstem GBM cells as what has been previously observed on GBM stem-like cell migration.
Observations of the two cell populations in 2D culture, showed a marked difference in
the morphology of the astrocytes and GBM cells. Despite been present at the same
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density, the astrocytes extended their body covering a considerable part of the whole
surface culture, while the GBM cells presented a predominantly rounded morphology
with occasionally spindle-like deformation during movement, and could be seen
spaciously distributed on the surface (Figure 4.3). Migration analysis of all the GBM cell
lines studied showed that presence of an astrocyte layer increases GBM migration. GBM
cells were able to reach almost 2-fold greater migration distances (both accumulated and
net) in presence of astrocytes than cultured alone (Fig 4.4 A, B). To further determine the
mechanism involved in increased GBM migration due to presence of astrocytes, we
evaluated migration of GBM cells cultured with astrocyte-conditioned media (ACM).
Presence of ACM did not increase migration. GBM cells cultured with ACM presented
similar migration distances to GBM cultured alone in normal media (Fig 4.4 A, B),
suggesting the dynamic interaction between the two populations caused a greater
migratory behavior of GBM cells.
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Figure 4.4 Presence of astrocytes but not astrocyte conditioned media increases GBM cell
migration. A. Accumulated distance of migration during 15 h. B. Net migration distance
between initial (0 h) and final points of migration (15 h). C. Directionality of migration
(accumulated over net distance). Bars indicate Mean ± SE from a population of 400-1500
individual cells. * Represents statistical difference at α=0.05

4.3.3

*
*

Presence of astrocytes increases GBM migration in 3D brain-like model

Given the effect of astrocytes presence on 2D GBM migration we further tested whether
the same effect was observed during 3D culture in a matrix that represents the physical
and compositional characteristics of the extracellular matrix (ECM) present in the GBM
microenvironment. Equal numbers of human astrocytes and GBM cells were
incorporated into the 3D matrix prior polymerization and GBM migration in 3D was

*

*
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analyzed. Similar to what was observed in liquid culture, presence of astrocytes increased
the 3D accumulated and net migration distance of all the GBM cell lines studied (Fig 4.5).

*
*
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*

*
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*

Figure 4.5 Presence of astrocytes increase migration of all GBM cultured in a 3D-brainlike model of collagen-hyaluronan. A. Accumulated distance of migration during 15 h. B.
Net migration distance between initial (0 h) and final points of migration (15 h). Bars
indicate Mean ± SE from a population of 400-1500 individual cells, from at least 2
independent repetitions * Represents statistical difference at α=0.05

In both cases, 2D liquid culture and in 3D-culture, presence of astrocytes increased GBM
migration. However, is important to note that direct physical contact between the two
population was certain in 2D (Figure 4.3) culture but not in 3D culture (Figure 4.6). In
the 3D matrix, GBM and astrocytes were seeded at a concentration in which direct
physical contact although probable was not predominant. Attempts to increase cell
concentration to maximize contact as occurs in vivo, resulted in rapid matrix contraction
and detachment of the constructa from the plates (data not shown).
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3D volume reconstruc/on
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Z-projec/on of stack for
movement analysis

Glioblastoma (GBM43)
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100 μm
Figure 4.6 Co-culture of Astrocytes and GBM cells in a 3D-matrix. Both cell populations
are homogeneously distributed within the matrix. At the cell density used for 3D culture
studies the cells generally do not present physical contact with each other. GBM cells
appear in green and astrocytes in red. Reconstruction of a volume of study with
dimensions z: 80 µm x: 460 µm y: 460 µm.
4.3.4 3D co-culture of astrocytes and GBM cells affects GBM expression of matrix
metalloproteinases (MMPs)

Increased GBM migration due to presence of astrocytes has been associated to physical
interaction between the two cell populations and communication through gap
junctions.23,112 However, having observed that in 3D co-culture physical contact was not
predominant, still the migration was higher in presence of astrocytes than during onlyGBM culture, we hypothesized that astrocytes could affect GBM 3D migration by
increasing the production of proteinases required for ECM degradation. Thus, we tested
the effect of astrocyte presence on the GBM expression of MMP-2, and MMP-9, both
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previously linked to GBM migration. Co-culture with astrocytes in the 3D model
increased GBM production of MMP-9 but has a differential effect on the expression of
MMP-2 (Fig 4.7). Presence of astrocytes slightly increased GBM10 expression of MMP2 (both pro-enzyme at 72 kDa and activated enzyme 66 kDa). In contrast MMP-2
expression decreased in GBM43 cells in the presence of astrocytes.

Figure 4.7 Presence of astrocytes during co-culture with GBM cells in a 3D brain-like
model increases expression of MMP-9 and has a differential effect on MMP-2 expression
(MMP-2 pro-enzyme: 72 kDa, MMP-2 active isoform: 66 kDa). 14µg of total protein
were loaded form each sample.

4.3.5

Dual presence of endothelial colony forming cells (ECFC) and astrocytes
increases GBM migration on 2D surfaces

The two principal structures used by GBM to migrate across healthy brain parenchyma
are axonal tracks and blood vessels.56 To evaluate the effect of vasculature-forming cells
on the migration of GBM we co-cultured endothelial colony forming cells (ECFCs) and
GBM cells at a ratio 1:1 as a monolayer on 2D surfaces and compared GBM migration
when cultured alone and when cultured with ECFCs. We observed that presence of
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ECFCs increased the accumulated and net migration of all GBM cell lines. The greatest
effect of ECFCs on migration was observed in the stem-like cell line GBAM1 where
presence of ECFCs increased accumulated migration more than 5-fold (Figure 4.8).

Given the increase of GBM migration observed due ECFCs and astrocytes as previously
shown, we incorporated astrocytes and ECFCs in the same culture with GBM cells (ratio
1:1:1) to determine a possible synergistic effect of both cell populations on GBM
migration. Dual presence of ECFCs-astrocytes further increased 2D GBM migration of
all GBM cell lines evaluated compared to cultures with only presence of ECFC and GBM.

Differential effect of ECFCs on migration of different GBM cell lines, suggests that
presence of only ECFCs has a greater effect on the migration of the stem-like cell line
GBAM1 compared to non-stem cell lines GBM10 and GBM43. In contrast, migration of
non-stem GBM cells is visibly increased by combined presence of ECFCs and astrocytes
but not significantly affected by the presence of ECFCs only (Figure 4.8).
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Figure 4.8 Co-culture with Endothelial colony forming cells (ECFCs) and astrocytes
drastically increases overall migration of GBM on 2D rigid surfaces. Dual co-culture of
GBM with ECFCs has great effect on GBAM1 migration but minimal influence on
migration of GBM10 or GBM43. A. Accumulated distance of migration during 15 h. B.
Net migration distance between initial (0 h) and final points of migration (15 h). C.
Directionality of migration (accumulated / net distance). Bars indicate Mean ± SE from a
population of 400-1500 individual cells. * Represents statistical difference at α=0.05.

4.3.6

Presence of ECFCs and astrocytes has an opposite effect on 3D migration of
stem-like and non-stem GBM cells

To corroborate that presence of ECFCs and combined astrocytes - ECFCs had a similar
effect in conditions more similar to in vivo settings; we used the 3D model of GBM ECM
to analyze GBM migration in presence of ECFCs and astrocytes - ECFCs. Similar to
what was observed in 2D, presence of ECFCs and dual presence of ECFCs and astrocytes
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increased the accumulated migration of the non-stem cell lines GBM10 and GBM43,
however, these co-culture conditions had the effect on the migration of stem-like cell line
GBAM1 (Figure 4.9). Analysis of net migration shows that in 3D culture, presence of
ECFCs or ECFC-astrocytes had no effect on the net distance covered by GBAM1;
suggesting that GBAM1 in co-culture migrates shorter distances but with more
directionality/persistence. Combined presence of ECFCs and astrocytes increased net
migration distance of the non-stem cells similar to what was observed in 2D culture.
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Figure 4.9 Dual presence of astrocytes and ECFCs increases accumulated migration
distance of non-stem GBM cells (GBM10, GBM43), but decreases migration of the stemlike GBM cell line GBAM1. A. Accumulated distance and B of migration during 15 h. B.
Net migration distance between initial (0 h) and final points of migration (15 h). Bars
indicate Mean ± SE from a population of 400-1500 individual cells. * Represents
statistical difference at α=0.05.

4.3.7 Presence of stromal cells increases directionality of GBM stem-like cells but
decreases directionality of non-stem cells during 3D migration

Directionality or persistence of migration is a fundamental characteristic of migration that
describes the real net migration achieved by the cell and involves how the cell respond to
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multiple environmental and intrinsic signals to stabilize or generate more protrusions
towards specific directions. Analysis of the directionality of migration in 3D culture
indicated that non-stem GBM cell lines decreased directionality (greater random
migration) in presence of stromal cells such as astrocytes, ECFCs or combination of both
(Fig 4.10). However, presence of stromal cells increased considerably the directionality
of the stem-like GBAM1 cells in the co-cultures evaluated (Fig 4.10). Given that in all
conditions the properties of the extracellular matrix and the distribution of the stromal
cells was homogeneous within the matrix, we suggest that presence of stromal cells
increases intrinsic directionality of GBM stem-like cells but has the contrary effect on
non-stem GBM cells.

Figure 4.10 Presence of stromal cells in a 3D model increases migration directionality of
GBM stem-like cells (GBAM1) but increases randomness of movement of non-stem
GBM cells. Bars indicate Mean ± SE from a population of 400-1500 individual cells. *
Represents statistical difference at α=0.05
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4.4

Discussion

Aggressive and diffuse invasion across healthy brain parenchyma is characteristic of
GBM. Despite the great efforts to surgically remove all the tumor cells, in many cases
residual tumor cells are left in the tissue, mainly due to the impossibility to differentiate
them from the peritumoral edema present at the margins tumor mass.
During tumor progression, cancer cells develop a dynamic relationship with the
microenvironment and alter normal brain cellular functions to form a niche that supports
tumor growth and expansion.30,53,104,106,113 Here, we investigated the role of different
components of the microenvironment such as presence of a GBM-like extracellular
matrix and presence of astrocytes and endothelial cells, on GBM migration. Our results
indicate that in a 3D environment GBM decreases the overall migration compared to
standard liquid culture. Moreover, presence of stromal cells in a 3D in vitro tumor model
increases the migration of non-stem GBM cell lines.

The majority of migration studies have used conventional migration assays on rigid
surfaces to study cancer cell migration, however tumor cells exist in a 3D environment in
presence of stromal cells and surrounded by ECM. Comparison of GBM migration when
cultured in 2D rigid surfaces and within a 3D model of GBM ECM shows that presence
of a 3D ECM reduces the migration of all GBM cell lines studied and increases the
intrinsic directionality of the cells. Morphology and cell adhesion have been found to be
different for cells cultured in 2D surfaces and within 3D matrices.114–116 Differences in
the mechanical and chemical clues provided by 2D or 3D platforms modulate in a
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different fashion the cellular processes involved in migration and ultimately affect
migration mode, velocity and directionality.

Stromal cells are fundamental components of the tumor microenvironment and
synergistically interact with cancer cells during tumor progression. Incorporation of
astrocytes in 2D monolayer culture increased migration distance and velocity of GBM.
Previous studies by Rath (2013)110 showed that astrocytes and astrocyte conditioned
media increase migration of GBM stem-like cells in a Transwell assay, but have no effect
on non-stem GBM cells. In contrast, we observed that presence of only astrocyte
conditioned media had no effect on increasing migration of non-stem GBM cells but
direct contact of the populations on a 2D surfaces increased GBM migration. It has been
recognized that direct communication between astrocytes and GBM through gap
junctions, and specifically through Connexin 43 (Cx43) increases migration.23,112
Nevertheless, our results showed that in the 3D model of GBM ECM where cells are
homogenously distributed and physical contact is not prevalent, incorporation of
astrocytes also increased GBM migration, suggesting that formation of heterocellular gap
junctions is not necessary for astrocytic effect on GBM migration.24

Regulation of GBM migration has been directly linked to astrocyte signaling through
either direct secretion of MMPs40,117 or secretion of neurotropic factors that induce cancer
MMPs expression. Studies by Le (2003)117 and Wang (2013)40 showed that astrocyte
expression of pro MMP-2 and pro MMP-9 increased GBM migration. Furthermore,
presence of glial derived-cell neurotrophic factor (GDNF), normally secreted by glial
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cells including astrocytes, enhances migration of cancers like human squamous cell
carcinoma,118 pancreatic cancer119 and GBM,21 possibly through up-regulation of tumor
MMP-9 expression. Yet, these studies have been performed in 2D liquid cultures, where
MMPs expression and activation are affected by the absence of a 3D ECM. We showed
that presence of astrocytes during 3D culture increases expression of GBM MMP-9.
Combining our observations with results by Okada (2003),119 we suggest that higher
expression of MMP-9 by GBM can be linked to astrocytic-secreted GDNF.

The role of endothelial cells in GBM progression has mainly being studied in the context
of tumor neovascularization through tumor expression of VEGF. However, the link
between neovascularization and VEGF has been proven to be more complex than initially
recognized, and extends to multiple tumor processes beyond vascularization. For instance,
vascular networks are used by GBM as migration highways; however, presence of VEGF
directly decreases GBM invasion120 and prolonged inhibition of VEGF cause ultimate
enhanced GBM migration as was observed in patients treated with Bevacizumab.121
Inhibition of interaction between the tumor and the endothelial cells, as well as inhibition
of angiogenesis through VEGF-A blockade by Bevacizumab can led to tumor invasion
and metastasis. The mechanism by which direct blockade of VEGF increases GBM
invasion is related to the hepatocyte growth factor (HGF) and its receptor MET.
MET/HGF interaction has been known to activate cell migration, however presence of
VEGF antagonizes MET/HGF interaction.120 Blockade of VEGF enhances MET/HGF
interaction and GBM cells display higher invasiveness.
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Interaction between tumor and endothelial cells has repercussions in multiple tumor
processes. Despite the fundamental role of endothelial cells as main components of the
tumor microenvironment, few studies have physically incorporated them into in vitro
models to study their effect on cancer cell behavior.122 Here, we demonstrated that dual
presence of endothelial cells and astrocytes increases the migration of non-stem GBM
cells on 2D and 3D platforms but decreases migration of stem-like GBM cells in a 3D
model of GBM ECM. Stem-like GBM cells, similar to neural progenitors reside in a
specific perivascular niche closely associated with blood vessels and endothelial cells.8,35
Although, stem-like GBM cells can present high migratory potential in other contexts as
we and others have shown,26,50 we suggest that in presence of an environment that
mimics the perivascular niche, they present reduced migration as the microenvironment
provides supportive and maintenance cues. In the same context, presence of stromal cells
increases the directionality of stem-like GBM cells, but decreases directionality of nonstem GBM cells. Differences in directionality can be attributed to differential intrinsic
response of stem-like GBM cells to external guidance cues provided by
microenvironment that regulates the cellular polarity machinery and stabilizes the cell
leading edge during migration to achieve directionality.80
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4.5

Summary

We investigated the role of the microenvironment in terms of presence of an ECM and
stromal cells like astrocytes and endothelial cells on migration of stem-like and non-stem
GBM cells. Our results demonstrate that presence of a 3D GBM-like ECM decreases
migration velocity, and distance and increases intrinsic directionality of GBM cells.
Presence of stromal cells either in dual or triple co-culture with GBM increases the
overall migration of GBM cells on 2D rigid surfaces. When dimensionality and stromal
cell are combined to evaluate their effect on GBM migration, presence of stromal cells
increases migration of non-stem GBM cells, however only astrocytes alone and not
ECFCs or ECFCs-astrocytes increase migration of stem-like GBM cells. This suggests a
direct role of endothelial cells on migration inhibition of stem-like GBM cells in a 3D
culture. In the same line, stromal cells present in a 3D environment decrease the
directionality of non-stem GBM cells but increase intrinsic directionality of stem-like
GBM cells. Incorporation of multiple components of the GBM microenvironment in an
in vitro controllable platform presents a powerful tissue-engineering tool to understand
how individual and combined factors modulate GBM behavior, and specific process that
are characteristic to GBM such as rapid migration.

94

CHAPTER 5. THE 3D MICROENVIRONMENT REGULATES STAT3
ACTIVATION AND RESPONSE TO DRUG INHIBITION IN GLIOBLASTOMA

5.1

Introduction

The activity of STAT3, a member of the Signal Transducer and Activator of
Transcription (STAT) family is modulated by the microenvironment. STAT3 regulates
multiple cellular processes such as proliferation, survival, angiogenesis and migration
(Fig 4.1).123 In normal cells, STAT3 is present in the cytoplasm as a non-phosphorylated
monomer and undergoes transient phosphorylation as a response to intracellular
activators as EGFR, Src and ERK, as well as extracellular signaling through direct
interaction with members of the Janus–activated kinases.123–125 Phosphorylation of
STAT3 can occur in Tyr-705 or Ser-727, however, the majority of STAT3 functions are
directly related to Tyr-705 phosphorylation. Phosphorylated STAT3 forms active
homodimers via interaction through the SH2 domains that translocate to the nucleus and
regulate the expression of multiple genes.

STAT3 has lately attracted interest as a potential cancer target due to its location as the
convergence point of multiple oncogenic pathways and constitutive activation in more
than 70% of all cancers.126 Gain of function mutation of STAT3 has not yet been reported.
STAT3 constitutive activation is usually due to a mutation in an upstream regulator.124 127
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In GBM basal STAT3 activation is widely variable; previous studies found that 9 to 83%
of GBM human tumors evaluated exhibited constitutive phosphorylated STAT3.125 The
role of STAT3 in gliomagenesis involves multiple cellular processes with survival and
migration being two of the most intensively studied. Constitutive activation of STAT3
directly upregulates expression of anti-apoptotic proteins Mcl-1, Bcl-2 and Bcl-XL and
increases survival.123,124 Likewise, constitutive activation of STAT3 has been linked to
the conversion of non-stem cells to stem-like cells in breast cancer128 as well as increased
self-renewal of GBM stem-like cells.129 Effect of STAT3 in migration is linked to
regulation of cell adhesion and cytoskeletal rearrangement mediated by RhoGTPases.
STAT3 association with NF-kB mediates glioma migration through the adhesion
molecule ICAM-1.130 Furthermore, inhibition of STAT3 expression has been shown to
inhibit the activity of RhoA and reduce phosphorylation of the focal adhesion protein
FAK as well reduce expression of MMPs.131

Constitutive STAT3 activation in cancers occurs as a response to deregulated cytokine
and chemokine signaling from the tumor microenvironment. STAT3 activation in cancer
can in turn be propagated to other stromal and immune cells via expression of signals
such as vascular endothelial growth factor (VEGF) and interleukin-10 (IL-10).41
Likewise, the presence of the ECM modulates the cell response to soluble signals,132 and
increases expression of adhesion molecules such as β1-integrin that induces STAT3
activation.133 Despite the fundamental role exerted by the microenvironment on STAT3,
the majority of studies that have evaluated STAT3 oncogenic function were performed in
platforms that do not recapitulate the fundamental aspects of the tumor microenvironment.
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STAT3 inhibition has been increasingly considered as possible route for GBM treatment.
Given the great effect that the microenvironment exerts on STAT3 activation, we suggest
that the use of in vitro models that recapitulate the characteristics GBM
microenvironment are one of the most appropriate platforms for the initial assessment of
drug treatments aimed to target STAT3 in GBM. In this study we investigated the impact
of the 3D microenvironment comprised by a GBM-like ECM and astrocytes on the basal
phosphorylation of STAT3, as well as the effect of the STAT3 inhibitor SH-4-54 on
viability and migration of patient-derived GBM cells.
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Figure 5.1 STAT3 regulates multiple pathways involved in cancer progression.
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5.2

5.2.1

Experimental Methods

Standard liquid cell culture

GBM human–derived cell lines GBM10, GBM43 and MHBT32 were maintained in highglucose DMEM (Life Technologies, Carlsbad, CA) supplemented with 10% FBS. GBM
human cell line GBAM1 (CD133+ >98%) was maintained in DMEM/F12 supplemented
with B27 without vitamin A (ThermoFisher Scientific, Waltham, MA) and with growth
factors EGF, bFGF (50 ng/ml each, Peprotech, Rocky hill, NJ). Human primary
astrocytes (ScienCell, Carlsbad, CA) were maintained according to vendor specifications.
All cell lines were cultured at 37°C in an atmosphere of 5% CO2, fed with complete
media every other day and passaged at 70-80% confluence.

5.2.2

Synthesis of 3D brain-like matrix and 3D cell culture

3D matrices of collagen-hyaluronan were generated using pig skin oligomer collagen
(GeniPhys, Zionsville, IN) at concentration of 2 mg/ml and sodium hyaluronate (MW
351-600) KDa (Lifecore Biomedical, Chaska, MN) was incorporated at 10 mg/ml as
described previously. Cells were suspended at the desired concentration in the 3D matrix
prior polymerization at 37°C for 30 minutes. Complete media was added to the top of the
matrix, and cells were cultured at 37°C in an atmosphere of 5% CO2. For 3D co-culture
of GBM and astrocytes, GBM cells were embedded in collagen-hyaluronan matrix at a
density of 3.5*105 cells in 200 µl of matrix, following polymerization 3.5*105 astrocytes
suspended in 200 µl of collagen matrix were pipetted to form a concentric ring as
described in Chapter 4.
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5.2.3

Drug treatment and cell viability analysis

GBM cells were cultured for 24h (in liquid medium or within the 3D Col-HA matrix) in a
96-well plate at 5000 cells/well with 100 µl of complete media prior addition of SH-4-54
inhibitor in DMSO vehicle. All treatments were normalized to control DMSO volume.
Viability of GBM cells cultured in liquid media and 3D collagen-hyaluronan matrix was
assessed by Alamar blue assay (ThermoFisher Scientific, Waltham, MA). After drug
treatment, cells were incubated with Alamar blue reagent during 3 h and absorbance was
measured at 570nm. Cells treated only with DMSO served as controls. Absorbance
readings were normalized to DMSO controls to calculate viability percentages.

5.2.4

RNA interfering assays

GBM43 and GBM10 were transfected by reverse transfection with STAT3 siRNA (Santa
Cruz Biotechnology, Dallas, TX). Briefly, 10 pmol of siRNA were diluted in 50 µl of
OptimMEM medium (ThermoFisher Scientific, Waltham, MA) and mixed with 3 µl of
Lipofectamine RNAimax (ThermoFisher Scientific, Waltham, MA) in 50 µl of OptiMEM
media. The mix was incubated at room temperature for 15min and added to a well of a
24-well plate. Then, 1*105 GBM10 or GBM43 cells suspended in OptiMEM media were
deposited per well containing the mix to a final volume of 300 µl/well. Cells were
incubated at 37°C in an atmosphere of 5% CO2 during 24 h and 300 µl of normal DMEM
media with 20% FBS were added to each well to stimulate cell attachment to the plate.
Forty-eight hours after transfection cells were recovered by trypsin exposure and cultured
accordingly for the migration assays. Negative transfection control was transfected with
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control-siRNA A and positive control with siRNA FITC conjugate-A (Santa Cruz
Biotechnology, Dallas, TX).
5.2.5

Western blot analysis

Cells cultured in 2D monolayer and in 3D brain-like matrix were were washed with icecold PBS and lysed with RIPA buffer supplemented with 1X Halt™ protease and
phosphatase inhibitor cocktail (ThermoFisher Scientific, Waltham, MA) at 4°C as
described in Chapter 3. For protein extraction of GBM co-cultured in 3D with astrocytes
the concentric ring was manually separated to obtain the layers containing each of the cell
populations. Total protein concentration was quantified and electrophoresed as described
in Chapter 3. Blotting of the membranes was done with primary antibodies against
STAT3-p705 (dilution 1:2000), STAT3-p727 (dilution 1:2000), STAT3 (1:1000), actin
(1:1000) (Cell Signaling, Danvers, MA). Secondary antibodies IRDye800CW anti-rabbit
and IRDye680RD anti-mouse (Licor, Cambridge, UK) were used at a dilution 1:2000.
Visualization was performed in Odyssey Clx System (Licor, Cambridge, UK).
Semiquantitative analysis of STAT3 activation was done in ImageJ. Bands corresponding
to phosphorylated STAT3 and total STAT3 were normalized to a ladder band to avoid
differences in multiple readings of the same membrane. STAT3 activation was quantified
as phosphorylated STAT3 over total STAT3.

5.2.6 Migration on 2D surfaces
Cells were tested for viability, stained with CellTracker™ Green CMFDA dye (Life
Technologies, Carlsbad, CA) for visualization and plated in a µ-slide angiogenesis
chamber (Ibidi, Germany) at a density of 15000 cell/cm2, fed with appropriate media and
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incubated during 4 h for attachment. Afterwards, cells were placed in an on-stage
incubator and treated with the SH-4-54 prior initiation of time-lapse confocal microscopy
during 15 h every 1.5 h.

5.2.7

Migration in 3D brain-like matrix

GBM cells were stained with CellTracker™ Green CMFDA dye (Life Technologies,
Carlsbad, CA) and embedded at a density of 1*106 cells/ml within the collagenhyaluronan matrix before polymerization. Volumes of 30 µl of matrix per well were
platted in a µ-slide angiogenesis chamber (Ibidi, Germany). After matrix polymerization,
30 µl of media was added per well and cells were maintained at 37°C in an atmosphere of
5% CO2 for 24 h, prior migration analysis. Drug SH-4-54 was added to the cultures
15min prior the initiation of migration analysis. During migration cells were imagined by
time-lapse confocal microscopy every 1.5 h during 15 h.

5.2.8

Time-lapse confocal imaging, analysis of migration and statistical analysis

Performed as described in Chapter 4.
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5.3

5.3.1

Results

Basal status of STAT3 in GBM during 2D liquid culture

Given the wide range of basal activation found in multiple GBM tumors, we initially
tested the status of STAT3 on tyrosine 705 and serine 727, the two phosphorylation sites
of STAT3 to check the constitutive status of STAT3. Cell lines GBM10, GBM43 and
GBAM1 showed very low to absent basal phosphorylation of Tyr-705 or iSer-727, while
the cell line MHBT32 presented basal phosphorylation in both active sites (Fig 5.2).
Given the low basal STAT3 activity in some cells, we stimulated with interleukin-6 (IL6), a well-recognized inducer of STAT3 activation, and checked the phosphorylation
status at varied timed after stimulation to account for the transient response characteristic
of STAT3. We observed that IL-6 stimulus induced Tyr-705 phosphorylation in the nonstem cell lines GBM10, GBM43 and MHBT32 but not in the stem-like line GBAM1 (Fig
5.2). As expected the activation was transient; phosphorylation occurred almost
immediately after stimulus and was maintained during the first hour but considerably
decreased by 2 h post stimulation. IL-6 did not cause phosphorylation of STAT3 on Ser727 in GBM10 or GBAM1, and had very slight effect on GBM43 and MHBT32 (Fig 5.2).
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Figure 5.2 STAT3 is constitutively activated (Tyr-705 and Ser-727) in MHBT32 but not
in GBM10, GBM43 and GBAM1. IL-6 stimulation caused transient phosphorylation of
STAT3 in all non-stem GBM cell lines but not in the stem-like GBAM1. Upper
horizontal section presents phosphorylation of Tyr-705 and lower section presents
phosphorylation on Ser 727. Total protein loaded per lane 12 µg GBM10, 13 µg
MHBT32 and 16 µg GBM43 and GBAM1.

5.3.2

GBM cells present constitutive STAT3 activation during culture in a 3D-model of
tumor microenvironment

Following the low basal activation in vitro by most of the GBM cell lines studied, and
based on the regulation that the microenvironment exerts on cellular behavior, we
evaluated basal STAT3 status in GBM when cultured in a 3D GBM-like ECM alone or in
presence of astrocytes.

All GBM cells cultured in the 3D model exhibited basal

activation of STAT3 although in differing degrees (Fig 5.3). GBM10, GBM43 and
GBAM1 that previously displayed very low to absent STAT3 basal activity, exhibited
high STAT3 activation in 3D culture. MHBT32 exhibited lower STAT3 activation and
general lower total STAT3 in 3D culture compared to 2D culture, yet basal activity was
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present in 3D culture. Interestingly, presence of astrocytes in the 3D-model did not
significantly alter STAT3GBM10
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Figure 5.3 GBM exhibits basal activation of STAT3 when cultured in a 3D matrix that
recapitulates characteristics of GBM ECM. Presence of astrocytes in 3D environment
increases by 2X basal STAT3 phosphorylation of GBAM1 compared to 3D culture
without astrocytes. Total protein loaded per lane from 2D culture: 12 µg GBM10, 13 µg
MHBT32 and 16 µg GBM43 and GBAM1, from 3D culture 14 µg GBM10, GBM43,
MHBT32 and 7 µg GBAM1.
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5.3.3

STAT3 inhibitor SH-4-54 decreases viability of stem-like GBM cells but has
minor effects on viability of non-stem GBM cells

STAT3 is involved in the regulation of multiple cell processes including apoptosis and
cell proliferation. Based on our previous results that show differential basal activity of
STAT3 mediated by the microenvironment, we assessed the effect of STAT3 inhibition
on GBM survival, both in 2D liquid and 3D culture. To this end we treated GBM with
varied concentrations of the small molecule STAT3 inhibitor SH-4-54, which binds to the
SH2 domain of STAT3 preventing phosphorylation and dimerization. In liquid culture,
SH-4-54 reduced cell viability of MHBT32 to 60% at concentrations as low as 5 µM, as
was expected given its basal activation of STAT3 (Fig 5.4). The effect of SH-4-54 on
GBM43 and GBM10, which did not present basal activation of STAT3 was minor. The
drug only decreased viability of GBM43 to 65% at 25 µM and not had any effect on
GBM10 viability. Interestingly, SH-4-54 was very effective in reducing viability of the
stem-like line GBAM1; concentrations as low as 2 µM reduced GBAM1 viability to
nearly 40%. Evaluation of the anti-STAT3 drug SH-4-54 in 3D culture showed less or
similar effect on GBM viability despite the fact that all lines presented basal activity of
STAT3 in 3D culture. Similar to what was observed in liquid culture, GBM10 was
unresponsive to treatment. MHBT32 that exhibited high sensitivity to SH-4-54 in 2D
culture presented no reduction in viability after treatment in 3D culture. Only GBM43
and GBAM1 cell lines exhibited viability decrease when treated with the inhibitor in 3D
culture. Overall, anti-STAT3 treatment was very effective at low concentrations in
reducing the viability of the stem-like line GBAM1 both in 2D and 3D cultures.
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Figure 5.4. GBM viability after anti-STAT3 treatment with SH-4-54. Stem-like GBAM1
cell line exhibited the highest sensitivity to SH-4-54, however the non-stem GBM cells
were less responsive to treatment, especially GBM10. Treatment in 3D was less efficient
in decreasing viability compared to treatment in liquid culture.

5.3.4

Inhibitor SH-4-54 decreases STAT3 phosphorylation in GBM43 but not in
GBM10

The varied results obtained when assessing the effect of SH-4-54 inhibitor on GBM
viability suggested dissimilar activity of the inhibitor on the various cell lines. To
corroborate that SH-4-54 was indeed inhibiting STAT3 phosphorylation, we tested the
SH-4-54-resistant cell line GBM10 and the SH-4-54-sensitive cell line GBM43 by
pretreating with increasing doses of SH-4-54 and subsequently stimulating STAT3
activation with IL-6. Unfortunately, testing of GBAM1 was not possible due lack of basal
STAT3 activation as well as unresponsiveness to IL-6 or EGF (data not shown)
stimulation. SH-4-54 did not inhibit STAT3 Tyr-705 phosphorylation in GBM10 at any
concentration evaluated (2-10 µM) (Fig 5.5), agreeing with the unresponsiveness
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observed in the survival tests. In contrast, the drug effectively inhibited STAT3 Tyr-705
phosphorylation in GBM43 cells and the degree of inhibition was proportional to the
concentration of drug evaluated.
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Figure 5.5 STAT3 inhibitor SH-4-54 effectively decreases STAT3 Tyr-705
phosphorylation in GBM43, but has no effect on STAT3 activity in GBM10. Total
protein loaded per lane 7 µg GBM10, 14 µg GBM43.

5.3.5

Inhibitor SH-4-54 decreases STAT3 migration of GBM43 but not in GBM10 in a
3D-model of GBM microenvironment

STAT3 regulates multiple genes involved in invasion and metastasis. We therefore,
tested the effect of STAT3 inhibition on migration of GBM10 and GBM43 on 2D
surfaces as well as in 3D brain-like matrix. Expression of STAT3 was inhibited by
siRNA in both lines as a control to validate the effect of STAT3 inhibition on migration.
Analysis of GBM10 and GBM43 migration distance in 2D surfaces showed that
knockdown or inhibition of STAT3 with SH-4-54 did not reduce GBM migration (Fig
5.6). In contrast, anti STAT3 treatments (STAT3 siRNA and SH-4-54) reduced the

107
migration of GBM43 in 3D culture. Interestingly, anti-STAT3 treatments did not the
migration of GBM10 cell line in the 3D model. Although, siRNA knockdown was only
60% in GBM10, the previous unresponsiveness of this particular cell line to the SH-4-54
inhibitor combined with unaffected survival and migration after treatment suggest a
possible impairment of STAT3 function. Our results show that SH-4-54 inhibitor
effectively decreases STAT3 activation in the GBM43 cell line and such inhibition
directly correlates with decreased survival and migration in 3D environments.
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5.4

Discussion

STAT3 is an attractive target for GBM treatment given its convenient location as a cross
point of many oncogenic pathways.126 STAT3 activation is mediated by signaling from
the microenvironment; nonetheless, the majority of STAT3 studies in GBM have been
performed in liquid platforms that do not recapitulate the main features of the tumor
microenvironment and might therefore lead to observations not representative of in vivo
context. In this study we demonstrated that presence of 3D microenvironment regulates
the basal activation of STAT3 in GBM and influences the effect of anti-STAT3 drug
treatment on survival and migration.
Multiple studies have shown constitutive activation of STAT3 in GBM tumor samples;
however, basal activation in GBM can be highly variable.123 Evaluation of STAT3 basal
activity of four patient-derived GBM cell lines showed that during culture in standard
liquid platforms, the GBM cell lines GBM10, GBM43 and the stem-like cell line
GBAM1 do not present constitutive phosphorylation of STAT3 in Tyr-705 or Ser-727,
the two active phosphorylation sites of STAT3. Only the line MHBT32 showed
constitutive activation of STAT3 in Tyr-705 and Ser-727.
STAT3 undergoes transient activation as a response to microenvironment signals such
IL-6 family cytokines and certain growth factors as endothelial growth factor (EGF).
Non-stem cell GBM lines were responsive to IL-6 stimulation and underwent transient
phosphorylation in Tyr-705, but not in Ser-727. STAT3 phosphorylation triggered by IL6 stimulation can occur in both active sites but through different signaling cascades.134
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Primary association of STAT3 and regulation of main processes as survival, proliferation
and invasion occurs though phosphorylation of Tyr-705, while phosphorylation of Ser727 potentiates Tyr-705 activation and controls metabolic activity.134,135 Differential
activation of Tyr-705 and not Ser-727 can be associated with the short-lived stimulus
applied that activates only the primary phosphorylation in Tyr-705 but is not sustained or
strong enough to trigger phosphorylation of Ser-727 in our experimental settings.
IL-6 is the most well known activator of STAT3. Interestingly, stimulation with IL-6 did
not trigger phosphorylation of STAT3 in the stem-like GBAM1. STAT3 activation has
been shown essential for maintenance of stem properties of the cancer stem-like
population through direct repression of genes involved in differentiation.136 Furthermore,
studies by Wang (2009)137 showed that direct stimulation of GBM stem-like
neurospheres with IL-6 increases activation of STAT3. IL-6 stimulation of the stem-like
line GBAM1 did not induce STAT3 activation as expected, however many factors could
have influence such outcome, for instance the lack of expression of IL-6 receptor. Further
studies are needed to understand the characteristics of this cell line in terms of STAT3
activation.
STAT3 functions as a signal transducer and is responsive to signals from the
microenvironment. In agreement, with previous studies regarding the fundamental role of
the microenvironment in STAT3 activation in cancer, incorporation of GBM cells in a 3D
model that recapitulates the properties of the brain extracellular matrix induced STAT3
basal activation. Further incorporation of astrocytes into the 3D ECM model increased
STAT3 phosphorylation of the stem-like line GBAM1. These results show that the
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recapitulation of the tumor microenvironment induces GBM basal STAT3 activation,
however, when the cells are isolated from their niche, as happens during standard 2D
culture, STAT3 basal activations is lost, and only GBM cells that harbor a mutation in an
upstream regulator show constitutive STAT3 activity.
Effect of inhibition of STAT3 phosphorylation by the small molecule SH-4-54 has been
effective to reduce survival of brain tumor initiating cells, both in liquid culture and in in
vivo models.90 Our observations corroborate the effectiveness of SH-4-54 reducing
viability of the stem-like line GBAM1 both in 2D liquid culture and in 3D culture,
despite the lack of basal activation in 2D culture previously observed. These results,
validate STAT3 inhibition as an effective treatment for targeting stem-like GBM
populations regardless of the basal activation status of STAT3. Our results also agree
with previous studies that emphasize the importance of STAT3 on proliferation and
survival of GBM stem-like cells. STAT3 function is essential non only for maintenance
of stem embryonic cells138 but also for survival of GBM stem-like cells.99,129,139
Nevertheless, SH-4-54 was less efficient in decreasing viability of non-stem GBM cells.

GBM viability after treatment with the inhibitor SH-4-54 showed that the effect of the
drug was greater in liquid culture despite the lack of basal STAT3 phosphorylation of
most of the cell lines studied. Interestingly, SH-4-54 showed less efficiency in decreasing
the viability of GBM cells in 3D culture despite the fact that all GBM cell lines showed
basal activation of STAT3 during 3D culture. The varied response of non-stem cells to
SH-4-54 was explained by the functionality of the molecule inhibiting STAT3
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phosphorylation. Our results showed that SH-4-54 effectively inhibits Tyr-705 STAT3
phosphorylation in GBM43 but not GBM10, suggesting that is potential as GBM
treatment is cell line dependent.

STAT3 regulation not only regulates survival and proliferation but also migration.
Activation of STAT3 in cancer cells induces up-regulation of p21, RhoA, matrix
metalloproteinases (MMPs) and phosphorylated FAK,131 all modulators of cancer
invasion. Previous studies have shown that silencing of STAT3 impairs migration of
gastric carcinoma cells131 and GBM cells.136,140 In our studies, knockdown of STAT3
with siRNA and treatment with SH-4-54 migration of GBM43 in 2D. In contrast, the
same anti-STAT3 treatments reduced the migration of GBM43 cells in a 3D environment,
supporting previous studies that have shown a reduction of 3D GBM migration after
STAT3 targeting.141 The differential effect of anti-STAT3 treatment on 2D and 3D
migration can be related to different basal STAT3 activation exhibited by GBM when
cultured in different platforms. We suggest that in 2D platforms targeting of STAT3 has
no visible effect given the lack that basal phosphorylation, while in 3D environments
STAT3 is constitutively active and direct targeting of STAT3 visibly reduces the ability
of GBM to migrate.
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5.5

Summary

STAT3 is activated by signaling from the microenvironment and regulates various
cellular processes implicated in gliomagenesis. Nevertheless, STAT3 function is usually
studied in absence of the main components of the tumor environment. In this study, we
investigated the effect of the 3D microenvironment on the basal activation of STAT3 and
the effect of anti-STAT3 drug treatment on survival and migration of GBM. Our results
demonstrate that presence of a 3D ECM induces GBM basal activation of STAT3 in cells
lines that do not show constitutive STAT3 activation during 2D culture. Treatment of
GBM cells with the STAT3 inhibitor SH-4-54 greatly reduces viability of stem-like GBM
cells but has a weaker effect on reducing viability of non-stem cell lines. Further
exploration of SH-4-54 function revealed that this drug effectively inhibits
phosphorylation of the non-stem GBM line GBM43 but has no visible effect on GBM10.
Evaluation of the STAT3 inhibition revealed that anti-STAT3 treatment decreases the
migration in 3D environments for the SH-4-54-responsive line GBM43 but not for the
SH-4-54-resistant line GBM10. Our results demonstrate the importance of the 3D
microenvironment on basal status of STAT3 in GBM. As a consequence, STAT3
inhibition has different effects on survival and migration when evaluated in 2D surfaces
compared to 3D matrices.
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CHAPTER 6. CONCLUSIONS AND FUTURE WORK

In this study we explored the influence of the 3D extracellular matrix and stromal cells on
the regulation of glioblastoma migration and drug response. Initially we addressed the
effect of the extracellular matrix properties of the migration characteristics of
glioblastoma neurospheres during 3D culture. By developing a composite matrix of
hyaluronan structurally supported by a collagen I oligomer that simulates the braintumor extracellular matrix composition and comparing with standard, Matrigel and
collagen type-I monomer matrices, we showed that glioblastoma cells altered their
migration mode and velocity depending on the matrix composition and mechanical
properties. Compositional characteristics of the extracellular matrix as presence of
hyaluronan reduced velocity and number of migratory cells, and physical features such
as stiffness or presence of topographical cues modulated the migration mechanisms
adopted by the cells. Further efforts to increase the complexity of the developed braintumor extracellular matrix towards a more similar platform to in vivo tissues, showed
that incorporation of stromal cells (astrocytes and endothelial cells) modulate
glioblastoma behavior. Presence of astrocytes reduced the cytotoxic effect of
temozolomide on glioblastoma stem cells compared to liquid culture only-GBM 3D
culture. Combined presence of astrocytes and endothelial cells in the 3D model of braintumor microenvironment increased the migration of non-stem GBM cells. However,
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presence of endothelial cells (ECFCs) decreased the migration ability of GBM stem-like
cells suggesting a possible role of endothelial cells on signalining cues to decrease the
migration activity stem-like GBM cells.
Use of the 3D model of brain-tumor microenvironment showed that the
microenvironment induced basal activation of STAT3 in glioblastoma that was not
evident during standard 2D culture. Therefore, making the 3D model of GBM
microenvironment a more appropriate platform for the analysis of anti-STAT3 drug
treatments. Moreover, presence of the extracellular matrix decreased the cytotoxicity of
STAT3 inhibition on glioblastoma and allowed a more mechanistic evaluation of the
effects of STAT3 inhibition on 3D glioblastoma migration.

The unique, multiparameter understanding of the 3D tumor microenvironment has
revealed striking aspects on cancer migration ranging from highlighting the importance
of ECM composition and physical properties to the modulation of GBM migration mode
and drug-response in the presence of stromal cells. Further steps building on the 3D
tumor microenvironment model present an exceptional opportunity for the generation of
effective therapies that can keep the pace of the challenges imposed by the alwaysevolving cancerous cells.
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